(-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of CYP1B1 mRNA CTD PMID:22079256 (-)-trans-epsilon-viniferin decreases activity EXP 6480464 epsilon-viniferin results in decreased activity of CYP1B1 protein CTD PMID:12818727 (R)-pantothenic acid increases expression EXP 6480464 Pantothenic Acid results in increased expression of CYP1B1 mRNA CTD PMID:19397697 (S)-naringenin multiple interactions EXP 6480464 naringenin binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 (S)-naringenin increases expression ISO RGD:10439 6480464 naringenin results in increased expression of CYP1B1 mRNA CTD PMID:31621310 1,2,3,4,6,7,8-Heptachlorodibenzodioxin increases expression ISO RGD:2460 6480464 1 more ... CTD PMID:25654323 , PMID:29738842 1,2,3,4,6,7,8-Heptachlorodibenzofuran increases expression ISO RGD:2460 6480464 1 more ... CTD PMID:25654323 , PMID:29738842 1,2,3,4,7,8-Hexachlorodibenzofuran increases expression ISO RGD:2460 6480464 1 more ... CTD PMID:25654323 , PMID:29738842 1,2,3,6,7,8-Hexachlorodibenzodioxin increases expression ISO RGD:2460 6480464 1 more ... CTD PMID:25654323 , PMID:29738842 1,2,3,7,8-Pentachlorodibenzodioxin increases expression EXP 6480464 1 more ... CTD PMID:24472611 , PMID:29738842 1,2,3,7,8-Pentachlorodibenzodioxin increases expression ISO RGD:2460 6480464 1 more ... CTD PMID:25654323 , PMID:29738842 1,2,3,7,8-Pentachlorodibenzodioxin increases expression ISO RGD:10439 6480464 1 more ... CTD PMID:23674508 1,3-Dinitropyrene multiple interactions EXP 6480464 [CYP1B1 protein co-treated with POR protein] results in decreased metabolism of 1, 3-dinitropyrene CTD PMID:11113705 1,4-dihydroxy-2-naphthoic acid multiple interactions ISO RGD:10439 6480464 [1, 4-dihydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA CTD PMID:27837168 1,4-dihydroxy-2-naphthoic acid multiple interactions EXP 6480464 [1, 4-dihydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA CTD PMID:27837168 1,4-naphthoquinone increases abundance EXP 6480464 CYP1B1 protein results in increased abundance of 1, 4-naphthoquinone CTD PMID:16243959 1,8-Dinitropyrene increases expression EXP 6480464 1, 8-dinitropyrene results in increased expression of CYP1B1 mRNA CTD PMID:21887816 1,8-Dinitropyrene multiple interactions EXP 6480464 [CYP1B1 protein co-treated with POR protein] results in increased metabolism of 1, 8-dinitropyrene CTD PMID:11113705 1-hydroxy-2-naphthoic acid multiple interactions EXP 6480464 [1-hydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA CTD PMID:27837168 1-hydroxy-2-naphthoic acid multiple interactions ISO RGD:10439 6480464 [1-hydroxy-2-naphthoic acid binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA CTD PMID:27837168 1-methylphenanthrene affects expression ISO RGD:2460 6480464 1-methylphenanthrene affects the expression of CYP1B1 mRNA CTD PMID:27099206 1-methylphenanthrene multiple interactions ISO RGD:2460 6480464 1-methylphenanthrene affects the reaction [Benzoapyrene affects the expression of CYP1B1 mRNA] CTD PMID:27099206 1-naphthol increases abundance EXP 6480464 CYP1B1 protein results in increased abundance of 1-naphthol CTD PMID:16243959 1-naphthol multiple interactions ISO RGD:10439 6480464 [1-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA CTD PMID:27837168 1-naphthyl isothiocyanate increases expression ISO RGD:2460 6480464 1-Naphthylisothiocyanate results in increased expression of CYP1B1 mRNA CTD PMID:30723492 1-nitropyrene increases expression EXP 6480464 1-nitropyrene results in increased expression of CYP1B1 mRNA CTD PMID:21887816 1-nitropyrene increases expression ISO RGD:10439 6480464 1-nitropyrene results in increased expression of CYP1B1 mRNA CTD PMID:12117779 1-nitropyrene increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of 1-nitropyrene CTD PMID:11525925 17alpha-ethynylestradiol decreases expression ISO RGD:2460 6480464 Ethinyl Estradiol results in decreased expression of CYP1B1 mRNA CTD PMID:12075121 17alpha-ethynylestradiol multiple interactions ISO RGD:2460 6480464 Ethinyl Estradiol inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:29649501 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYP1B1 mRNA more ... CTD PMID:15142886 more ... 17beta-estradiol decreases expression ISO RGD:2460 6480464 Estradiol results in decreased expression of CYP1B1 mRNA CTD PMID:31119341 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP1B1 mRNA CTD PMID:16474171 more ... 17beta-estradiol increases expression ISO RGD:2460 6480464 Estradiol results in increased expression of CYP1B1 mRNA, Estradiol results in increased expression of CYP1B1 protein CTD PMID:8674863 17beta-estradiol multiple interactions ISO RGD:2460 6480464 [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benzaanthracene results in increased expression of CYP1B1 protein] more ... CTD PMID:26945725 more ... 17beta-estradiol multiple interactions ISO RGD:10439 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of CYP1B1 mRNA] CTD PMID:16280380 17beta-estradiol increases expression ISO RGD:10439 6480464 Estradiol results in increased expression of CYP1B1 mRNA CTD PMID:16280380 17beta-estradiol increases activity EXP 6480464 Estradiol results in increased activity of CYP1B1 protein CTD PMID:15157572 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP1B1 mRNA CTD PMID:16474171 17beta-estradiol increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of Estradiol CTD PMID:15377160 17beta-estradiol affects metabolic processing EXP 6480464 CYP1B1 protein affects the metabolism of Estradiol CTD PMID:15142886 , PMID:15507517 17beta-estradiol increases hydroxylation EXP 6480464 CYP1B1 protein polymorphism results in increased hydroxylation of Estradiol, CYP1B1 protein results in increased hydroxylation of Estradiol CTD PMID:11074351 more ... 17beta-estradiol 3-benzoate decreases expression ISO RGD:2460 6480464 estradiol 3-benzoate results in decreased expression of CYP1B1 protein CTD PMID:24752506 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of CYP1B1 mRNA CTD PMID:29581250 2'-deoxyguanosine multiple interactions EXP 6480464 CYP1B1 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine] CTD PMID:21907773 2'-hydroxychalcone decreases activity EXP 6480464 2'-hydroxychalcone results in decreased activity of CYP1B1 protein CTD PMID:15596260 2'-hydroxychalcone multiple interactions EXP 6480464 2'-hydroxychalcone inhibits the reaction [9 more ... CTD PMID:15596260 2,2',4,4',5,5'-hexachlorobiphenyl affects expression EXP 6480464 2 more ... CTD PMID:20638727 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:20959002 , PMID:25654323 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19095052 2,2',4,5-tetrachlorobiphenyl increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:25654323 , PMID:29738842 2,2',5,5'-tetrachlorobiphenyl affects response to substance EXP 6480464 CYP1B1 protein affects the susceptibility to 2 more ... CTD PMID:27913846 2,3',4,4',5,5'-Hexachlorobiphenyl increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:25654323 , PMID:29738842 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:10439 6480464 2 more ... CTD PMID:23674508 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:25654323 , PMID:29738842 2,3,3',4,4',5,5'-Heptachlorobiphenyl increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:25654323 2,3,3',4,4',5-Hexachlorobiphenyl increases expression ISO RGD:10439 6480464 2 more ... CTD PMID:23674508 2,3,3',4,4',5-Hexachlorobiphenyl increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:25654323 , PMID:29738842 2,3,4,3',4'-Pentachlorobiphenyl increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:25654323 , PMID:29738842 2,3,4,7,8-Pentachlorodibenzofuran multiple interactions EXP 6480464 2 more ... CTD PMID:21703235 2,3,4,7,8-Pentachlorodibenzofuran increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:21724226 more ... 2,3,4,7,8-Pentachlorodibenzofuran increases expression ISO RGD:10439 6480464 2 more ... CTD PMID:23674508 2,3,4,7,8-Pentachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:19358281 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2 more ... CTD PMID:10696073 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10439 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1B1 more ... CTD PMID:10037446 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10439 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1B1 mRNA CTD PMID:15037607 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity EXP 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein CTD PMID:14637189 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:2460 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein CTD PMID:19497421 , PMID:7588239 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2460 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1B1 mRNA CTD PMID:22298810 , PMID:28341572 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1B1 mRNA, Tetrachlorodibenzodioxin affects the expression of CYP1B1 protein CTD PMID:22298810 , PMID:31887333 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP1B1 mRNA CTD PMID:17101203 , PMID:22262711 2,3,7,8-tetrachlorodibenzodioxine affects localization EXP 6480464 Tetrachlorodibenzodioxin affects the localization of CYP1B1 protein CTD PMID:19138946 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10439 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP1B1 mRNA CTD PMID:14728982 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10439 6480464 2-methyl-2H-pyrazole-3-carboxylic acid 2-methyl-4-o-tolylazophenylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein] more ... CTD PMID:10037446 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2460 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA, Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein CTD PMID:10568693 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2460 6480464 2-methyl-2H-pyrazole-3-carboxylic acid 2-methyl-4-o-tolylazophenylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] more ... CTD PMID:12859982 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1B1 more ... CTD PMID:10067811 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:21703235 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO RGD:2460 6480464 2 more ... CTD PMID:20951181 more ... 2,3,7,8-Tetrachlorodibenzofuran multiple interactions EXP 6480464 2 more ... CTD PMID:21703235 2,4-D increases expression ISO RGD:2460 6480464 2, 4-Dichlorophenoxyacetic Acid results in increased expression of CYP1B1 mRNA CTD PMID:10910964 2,4-diaminotoluene increases expression ISO RGD:10439 6480464 2, 4-diaminotoluene results in increased expression of CYP1B1 mRNA CTD PMID:20713471 2,4-dichlorophenol affects binding EXP 6480464 2, 4-dichlorophenol binds to CYP1B1 protein CTD PMID:32278787 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO RGD:10439 6480464 Verapamil results in decreased activity of CYP1B1 protein CTD PMID:18420780 2-acetamidofluorene increases expression ISO RGD:10439 6480464 2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA CTD PMID:17317680 , PMID:20713471 2-acetamidofluorene multiple interactions ISO RGD:10439 6480464 TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1B1 mRNA] CTD PMID:17317680 2-hydroxy-17beta-estradiol multiple interactions EXP 6480464 CYP1B1 protein affects the metabolism of [2-hydroxyestradiol co-treated with Glutathione] CTD PMID:14679015 2-naphthol multiple interactions ISO RGD:10439 6480464 [2-naphthol binds to and results in increased activity of AHR protein] which results in increased expression of CYP1B1 mRNA CTD PMID:27837168 3',5'-cyclic AMP increases expression ISO RGD:10439 6480464 Cyclic AMP results in increased expression of CYP1B1 mRNA, Cyclic AMP results in increased expression of CYP1B1 protein CTD PMID:12859982 3',5'-cyclic AMP increases expression ISO RGD:2460 6480464 Cyclic AMP results in increased expression of CYP1B1 mRNA CTD PMID:12859982 3',5'-cyclic AMP multiple interactions ISO RGD:2460 6480464 AHR protein promotes the reaction [Cyclic AMP results in increased expression of CYP1B1 mRNA] more ... CTD PMID:12859982 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:2460 6480464 TNF protein promotes the reaction [3 more ... CTD PMID:17557910 3,3',4,4',5-pentachlorobiphenyl affects expression ISO RGD:10439 6480464 3 more ... CTD PMID:31563530 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:15041469 more ... 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:22262711 3,3',4,4',5-pentachlorobiphenyl affects expression EXP 6480464 3 more ... CTD PMID:21703328 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid 2-methyl-4-o-tolylazophenylamide inhibits the reaction [3 more ... CTD PMID:21513769 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:10439 6480464 3 more ... CTD PMID:24378064 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:10439 6480464 Sunphenon promotes the reaction [3 more ... CTD PMID:24378064 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:2460 6480464 3 more ... CTD PMID:15908097 more ... 3,3',4,4'-tetrachlorobiphenyl increases expression ISO RGD:10439 6480464 3 more ... CTD PMID:12117779 3,3',4,4'-tetrachlorobiphenyl increases response to substance EXP 6480464 CYP1B1 protein results in increased susceptibility to 3 more ... CTD PMID:31733235 3,3',4,4'-tetrachlorobiphenyl increases expression ISO RGD:2460 6480464 3 more ... CTD PMID:25654323 , PMID:29738842 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:10439 6480464 tetrabromobisphenol A results in decreased expression of CYP1B1 mRNA CTD PMID:25172293 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:2460 6480464 tetrabromobisphenol A results in increased expression of CYP1B1 mRNA CTD PMID:26988606 , PMID:28300664 3,3'-diindolylmethane increases expression EXP 6480464 3 more ... CTD PMID:11294972 3,4,5,3',4',5'-Hexachlorobiphenyl increases expression ISO RGD:2460 6480464 3 more ... CTD PMID:25654323 , PMID:29738842 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of CYP1B1 mRNA CTD PMID:24172598 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:10439 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of CYP1B1 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10439 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CYP1B1 mRNA, [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CYP1B1 protein CTD PMID:15967407 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of CYP1B1 mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions EXP 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to CYP1B1 promoter] more ... CTD PMID:11502733 more ... 3-methylcholanthrene increases expression ISO RGD:2460 6480464 Methylcholanthrene results in increased expression of CYP1B1 mRNA, Methylcholanthrene results in increased expression of CYP1B1 protein CTD PMID:11323195 more ... 3-methylcholanthrene multiple interactions ISO RGD:2460 6480464 alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA] CTD PMID:27163632 3-methylcholanthrene increases expression ISO RGD:10439 6480464 Methylcholanthrene results in increased expression of CYP1B1 mRNA, Methylcholanthrene results in increased expression of CYP1B1 protein CTD PMID:10402558 more ... 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP1B1 mRNA, Methylcholanthrene results in increased expression of CYP1B1 protein CTD PMID:11502733 more ... 3-methylcholanthrene increases metabolic processing ISO RGD:10439 6480464 CYP1B1 protein results in increased metabolism of Methylcholanthrene CTD PMID:11922910 3-methylcholanthrene increases chemical synthesis ISO RGD:10439 6480464 CYP1B1 protein results in increased chemical synthesis of Methylcholanthrene metabolite CTD PMID:11922910 3-Methylchrysene increases expression EXP 6480464 3-methylchrysene results in increased expression of CYP1B1 mRNA, 3-methylchrysene results in increased expression of CYP1B1 protein CTD PMID:31087746 3-Nitrofluoranthene multiple interactions EXP 6480464 [CYP1B1 protein co-treated with POR protein] results in decreased metabolism of 3-nitrofluoranthene CTD PMID:11113705 4',5,7-trihydroxy-3'-methoxyflavone multiple interactions EXP 6480464 chrysoeriol inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:20553787 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of CYP1B1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:10439 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of CYP1B1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:10439 6480464 bis4-hydroxyphenylsulfone results in increased expression of CYP1B1 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 CYP1B1 protein affects the metabolism of and results in increased activity of 4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone, Grape Seed Proanthocyanidins inhibits the reaction [4-N-methyl-N-nitrosamino-1-3-pyridyl-1-butanone results in increased expression of CYP1B1 mRNA] CTD PMID:11774366 , PMID:20146248 4-hydroxy-17beta-estradiol affects chemical synthesis EXP 6480464 CYP1B1 protein affects the chemical synthesis of 4-hydroxyestradiol CTD PMID:15142886 4-hydroxy-17beta-estradiol increases chemical synthesis EXP 6480464 CYP1B1 gene polymorphism results in increased chemical synthesis of 4-hydroxyestradiol CTD PMID:18187806 4-hydroxy-17beta-estradiol multiple interactions EXP 6480464 CYP1B1 protein affects the metabolism of [4-hydroxyestradiol co-treated with Glutathione], resveratrol inhibits the reaction [CYP1B1 protein affects the chemical synthesis of 4-hydroxyestradiol] CTD PMID:14679015 , PMID:15142886 4-hydroxychalcone decreases activity EXP 6480464 4-hydroxychalcone results in decreased activity of CYP1B1 protein CTD PMID:15596260 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of CYP1B1 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression ISO RGD:10439 6480464 Fenretinide results in increased expression of CYP1B1 mRNA CTD PMID:28973697 4-methoxy-17beta-estradiol multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased abundance of 4-methoxyestradiol], Tetradecanoylphorbol Acetate promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased abundance of 4-methoxyestradiol]] CTD PMID:9706865 4-methoxy-17beta-estradiol increases abundance EXP 6480464 CYP1B1 protein results in increased abundance of 4-methoxyestradiol CTD PMID:9706865 4-Methylchrysene increases expression EXP 6480464 4-methylchrysene results in increased expression of CYP1B1 mRNA, 4-methylchrysene results in increased expression of CYP1B1 protein CTD PMID:31087746 4-nonylphenol decreases expression ISO RGD:2460 6480464 4-nonylphenol results in decreased expression of CYP1B1 mRNA CTD PMID:27087316 , PMID:27109770 5,7-dihydroxy-4'-methoxyflavone increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of acacetin CTD PMID:21482471 5,7-dihydroxy-4'-methoxyflavone decreases activity EXP 6480464 acacetin results in decreased activity of CYP1B1 protein CTD PMID:10781868 5,7-dihydroxy-4'-methoxyflavone increases expression EXP 6480464 acacetin results in increased expression of CYP1B1 mRNA CTD PMID:31621310 5,7-dihydroxy-4'-methoxyflavone increases expression ISO RGD:10439 6480464 acacetin results in increased expression of CYP1B1 mRNA CTD PMID:31621310 5,7-dihydroxy-4'-methoxyflavone multiple interactions EXP 6480464 acacetin binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 5-aza-2'-deoxycytidine decreases methylation EXP 6480464 Decitabine results in decreased methylation of CYP1B1 promoter CTD PMID:20631054 5-aza-2'-deoxycytidine affects methylation EXP 6480464 Decitabine affects the methylation of CYP1B1 gene CTD PMID:17630775 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of CYP1B1 mRNA CTD PMID:17145863 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:20631054 5-azacytidine multiple interactions EXP 6480464 Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:12927368 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of CYP1B1 mRNA CTD PMID:12927368 , PMID:27590069 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CYP1B1 mRNA CTD PMID:25826687 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP1B1 mRNA CTD PMID:12040753 more ... 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter] more ... CTD PMID:21703235 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity ISO RGD:10439 6480464 Omeprazole results in decreased activity of CYP1B1 protein CTD PMID:18420780 5-Methylchrysene increases expression EXP 6480464 5-methylchrysene results in increased expression of CYP1B1 mRNA, 5-methylchrysene results in increased expression of CYP1B1 protein CTD PMID:31087746 6-chrysenamine increases expression ISO RGD:10439 6480464 6-chrysenamine results in increased expression of CYP1B1 mRNA CTD PMID:12117779 6-hydroxyluteolin increases chemical synthesis EXP 6480464 CYP1B1 protein results in increased chemical synthesis of 6-hydroxyluteolin CTD PMID:19666078 6-hydroxyluteolin multiple interactions EXP 6480464 [CYP1B1 protein affects the metabolism of scutellarein] which results in increased chemical synthesis of 6-hydroxyluteolin CTD PMID:19666078 6-Methylchrysene increases expression EXP 6480464 6-methylchrysene results in increased expression of CYP1B1 mRNA, 6-methylchrysene results in increased expression of CYP1B1 protein CTD PMID:31087746 6-Nitrobenzo[a]pyrene increases expression EXP 6480464 6-nitrobenzoapyrene results in increased expression of CYP1B1 mRNA CTD PMID:12107646 6-Nitrochrysene increases expression EXP 6480464 6-nitrochrysene results in increased expression of CYP1B1 mRNA CTD PMID:12107646 6-prenylnaringenin increases expression EXP 6480464 6-prenylnaringenin results in increased expression of CYP1B1 mRNA CTD PMID:27269377 6-propyl-2-thiouracil decreases expression ISO RGD:2460 6480464 Propylthiouracil results in decreased expression of CYP1B1 mRNA CTD PMID:24780913 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:12097275 more ... 7,12-dimethyltetraphene increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:32553695 7,12-dimethyltetraphene increases expression ISO RGD:2460 6480464 9 more ... CTD PMID:18205319 , PMID:26945725 7,12-dimethyltetraphene multiple interactions ISO RGD:2460 6480464 Estradiol inhibits the reaction [9 more ... CTD PMID:26945725 , PMID:7588239 7,12-dimethyltetraphene increases metabolic processing ISO RGD:2460 6480464 CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:7588239 , PMID:8674863 7,12-dimethyltetraphene increases metabolic processing ISO RGD:10439 6480464 CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:10037446 more ... 7,12-dimethyltetraphene affects response to substance ISO RGD:10439 6480464 CYP1B1 protein affects the susceptibility to 9 more ... CTD PMID:15331171 more ... 7,12-dimethyltetraphene increases response to substance ISO RGD:10439 6480464 CYP1B1 protein results in increased susceptibility to 9 more ... CTD PMID:11323178 more ... 7,12-dimethyltetraphene increases activity ISO RGD:10439 6480464 CYP1B1 protein results in increased activity of 9 more ... CTD PMID:15606143 7,12-dimethyltetraphene increases activity EXP 6480464 9 more ... CTD PMID:17183067 7,12-dimethyltetraphene multiple interactions EXP 6480464 2'-hydroxychalcone inhibits the reaction [9 more ... CTD PMID:12097275 more ... 7,12-dimethyltetraphene increases expression ISO RGD:10439 6480464 9 more ... CTD PMID:11559018 more ... 7,12-dimethyltetraphene multiple interactions ISO RGD:10439 6480464 1-ethynylpyrene inhibits the reaction [CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:10037446 more ... 7-hydroxyflavone multiple interactions EXP 6480464 7-hydroxyflavone binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 mRNA CTD PMID:22079614 8-Br-cAMP increases expression ISO RGD:2460 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 mRNA, 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 protein CTD PMID:7588239 9-phenanthrol multiple interactions EXP 6480464 [CYP1B1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol CTD PMID:27137136 9-phenanthrol increases abundance EXP 6480464 CYP1B1 protein results in increased abundance of 9-phenanthrol CTD PMID:27137136 acenaphthene increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of acenaphthene CTD PMID:25642975 acenaphthene multiple interactions EXP 6480464 [CYP1B1 protein results in increased oxidation of acenaphthene] which results in increased chemical synthesis of acenaphthene-1-ol CTD PMID:25642975 acenaphthylene increases expression ISO RGD:10439 6480464 acenaphthylene results in increased expression of CYP1B1 mRNA CTD PMID:10402558 acenaphthylene increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of acenaphthylene CTD PMID:25642975 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [NSC 674495 results in increased expression of CYP1B1 mRNA] CTD PMID:11752201 actinomycin D multiple interactions ISO RGD:2460 6480464 Dactinomycin inhibits the reaction [Vehicle Emissions results in increased expression of CYP1B1 protein] CTD PMID:21867498 actinomycin D decreases expression ISO RGD:10439 6480464 Dactinomycin results in decreased expression of CYP1B1 mRNA CTD PMID:11577022 actinomycin D multiple interactions ISO RGD:10439 6480464 Dactinomycin inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:11577022 adefovir pivoxil increases expression EXP 6480464 adefovir dipivoxil results in increased expression of CYP1B1 mRNA CTD PMID:25596134 afimoxifene multiple interactions EXP 6480464 afimoxifene inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CYP1B1 promoter]] CTD PMID:19460354 afimoxifene increases expression EXP 6480464 afimoxifene results in increased expression of CYP1B1 mRNA CTD PMID:19901195 afimoxifene decreases activity EXP 6480464 afimoxifene results in decreased activity of CYP1B1 protein CTD PMID:12419016 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of CYP1B1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYP1B1 mRNA CTD PMID:32234424 aflatoxin B1 multiple interactions EXP 6480464 CYP1B1 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine] CTD PMID:21907773 AH23848 multiple interactions EXP 6480464 AH 23848 inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 mRNA], AH 23848 inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 protein] CTD PMID:20093341 aldehydo-D-glucose multiple interactions EXP 6480464 [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein], [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein CTD PMID:28400208 alizarin decreases activity EXP 6480464 alizarin results in decreased activity of CYP1B1 protein CTD PMID:12379470 all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with arsenic trioxide] results in decreased expression of CYP1B1 mRNA more ... CTD PMID:15075337 more ... all-trans-retinoic acid multiple interactions ISO RGD:10439 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of CYP1B1 mRNA more ... CTD PMID:30951980 all-trans-retinoic acid decreases activity ISO RGD:10439 6480464 Tretinoin results in decreased activity of CYP1B1 protein CTD PMID:18420780 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CYP1B1 mRNA CTD PMID:12870655 more ... all-trans-retinol increases oxidation ISO RGD:10439 6480464 CYP1B1 protein results in increased oxidation of Vitamin A CTD PMID:15258110 all-trans-retinol increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of Vitamin A CTD PMID:15258110 Aloe emodin decreases activity EXP 6480464 aloe emodin results in decreased activity of CYP1B1 protein CTD PMID:27633141 alpha-naphthoflavone increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of alpha-naphthoflavone CTD PMID:16120791 alpha-naphthoflavone affects binding EXP 6480464 CYP1B1 protein binds to alpha-naphthoflavone CTD PMID:27966929 alpha-naphthoflavone multiple interactions ISO RGD:2460 6480464 alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA] CTD PMID:27163632 alpha-naphthoflavone multiple interactions ISO RGD:10439 6480464 alpha-naphthoflavone inhibits the reaction [AHR protein promotes the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA]] CTD PMID:11577022 alpha-naphthoflavone increases expression EXP 6480464 alpha-naphthoflavone results in increased expression of CYP1B1 mRNA CTD PMID:22262711 alpha-naphthoflavone decreases expression EXP 6480464 alpha-naphthoflavone results in decreased expression of CYP1B1 mRNA CTD PMID:22262711 alpha-naphthoflavone decreases activity EXP 6480464 alpha-naphthoflavone results in decreased activity of CYP1B1 protein CTD PMID:15280921 alpha-naphthoflavone multiple interactions EXP 6480464 alpha-naphthoflavone binds to and results in decreased activity of CYP1B1 protein more ... CTD PMID:15075337 more ... amentoflavone decreases activity EXP 6480464 amentoflavone results in decreased activity of CYP1B1 protein CTD PMID:16271822 amiodarone decreases response to substance EXP 6480464 CYP1B1 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 ammonium chloride affects expression ISO RGD:2460 6480464 Ammonium Chloride affects the expression of CYP1B1 mRNA CTD PMID:16483693 amodiaquine decreases response to substance EXP 6480464 CYP1B1 protein results in decreased susceptibility to Amodiaquine CTD PMID:31629065 amodiaquine multiple interactions EXP 6480464 [CYP1B1 protein results in increased metabolism of Amodiaquine] which results in increased abundance of desethylamodiaquine CTD PMID:31629065 amodiaquine increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of Amodiaquine CTD PMID:31629065 andrographolide multiple interactions ISO RGD:10439 6480464 [andrographolide co-treated with benzaanthracene] results in increased expression of CYP1B1 mRNA, andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA] CTD PMID:17825862 , PMID:19737545 aniline multiple interactions EXP 6480464 CYP1B1 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 anthracene increases expression EXP 6480464 anthracene results in increased expression of CYP1B1 mRNA CTD PMID:21668866 anthraflavic acid increases expression EXP 6480464 2, 6-dihydroxyanthraquinone results in increased expression of CYP1B1 mRNA CTD PMID:11502733 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of CYP1B1 mRNA CTD PMID:24449571 apigenin multiple interactions EXP 6480464 [CYP1B1 protein results in increased metabolism of genkwanin] which results in increased chemical synthesis of Apigenin, Apigenin binds to and results in decreased activity of CYP1B1 protein CTD PMID:19666078 , PMID:21053930 apigenin increases expression EXP 6480464 Apigenin results in increased expression of CYP1B1 mRNA CTD PMID:31621310 apigenin multiple interactions ISO RGD:10439 6480464 Apigenin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA] CTD PMID:20930378 apigenin decreases activity EXP 6480464 Apigenin results in decreased activity of CYP1B1 protein CTD PMID:16271822 , PMID:21482471 apigenin increases chemical synthesis EXP 6480464 CYP1B1 protein results in increased chemical synthesis of Apigenin CTD PMID:19666078 arachidonic acid affects metabolic processing EXP 6480464 CYP1B1 protein affects the metabolism of Arachidonic Acid CTD PMID:15258110 arachidonic acid affects metabolic processing ISO RGD:10439 6480464 CYP1B1 protein affects the metabolism of Arachidonic Acid CTD PMID:15258110 Aroclor 1254 increases expression ISO RGD:2460 6480464 Chlorodiphenyl 54% Chlorine results in increased expression of CYP1B1 mRNA CTD PMID:11323195 , PMID:18178546 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl 54% Chlorine results in increased expression of CYP1B1 mRNA CTD PMID:17851650 arsane affects methylation EXP 6480464 Arsenic affects the methylation of CYP1B1 gene CTD PMID:25304211 arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYP1B1 mRNA CTD PMID:32525701 arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of CYP1B1 gene CTD PMID:25304211 arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYP1B1 mRNA CTD PMID:32525701 arsenite ion increases expression ISO RGD:10439 6480464 Arsenites results in increased expression of CYP1B1 mRNA CTD PMID:22680237 arsenite(3-) multiple interactions ISO RGD:10439 6480464 [arsenite co-treated with Benzoapyrene] results in increased expression of CYP1B1 mRNA CTD PMID:15894712 arsenite(3-) decreases expression ISO RGD:10439 6480464 arsenite results in decreased expression of CYP1B1 mRNA CTD PMID:15894712 arsenous acid multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYP1B1 mRNA, Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of CYP1B1 protein] CTD PMID:15894607 , PMID:29876539 arsenous acid affects expression EXP 6480464 Arsenic Trioxide affects the expression of CYP1B1 mRNA CTD PMID:17530438 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CYP1B1 protein CTD PMID:29876539 atrazine increases expression ISO RGD:2460 6480464 Atrazine results in increased expression of CYP1B1 mRNA CTD PMID:26923738 atrazine multiple interactions ISO RGD:10439 6480464 lycopene affects the reaction [Atrazine results in increased expression of CYP1B1 mRNA] CTD PMID:26775023 atrazine increases expression ISO RGD:10439 6480464 Atrazine results in increased expression of CYP1B1 mRNA CTD PMID:26775023 atrazine multiple interactions ISO RGD:2460 6480464 Atrazine inhibits the reaction [Chorionic Gonadotropin results in decreased expression of CYP1B1 mRNA] CTD PMID:26923738 avobenzone decreases expression EXP 6480464 avobenzone results in decreased expression of CYP1B1 mRNA CTD PMID:31016361 baicalein decreases activity EXP 6480464 baicalein results in decreased activity of CYP1B1 protein CTD PMID:21482471 baicalein increases chemical synthesis EXP 6480464 CYP1B1 protein results in increased chemical synthesis of baicalein CTD PMID:19666078 baicalein multiple interactions EXP 6480464 [CYP1B1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein more ... CTD PMID:12224597 more ... belinostat increases expression EXP 6480464 belinostat results in increased expression of CYP1B1 mRNA CTD PMID:26272509 benzene decreases expression EXP 6480464 Benzene results in decreased expression of CYP1B1 mRNA CTD PMID:20359517 benzene-1,2,4-triol increases expression EXP 6480464 hydroxyhydroquinone results in increased expression of CYP1B1 mRNA CTD PMID:17572062 benzo[a]pyrene multiple interactions EXP 6480464 2' more ... CTD PMID:11279601 more ... benzo[a]pyrene affects methylation EXP 6480464 Benzoapyrene affects the methylation of CYP1B1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of CYP1B1 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene increases metabolic processing ISO RGD:10439 6480464 CYP1B1 protein results in increased metabolism of Benzoapyrene CTD PMID:32553695 benzo[a]pyrene increases response to substance EXP 6480464 CYP1B1 protein results in increased susceptibility to Benzoapyrene CTD PMID:27913846 , PMID:31733235 benzo[a]pyrene affects expression ISO RGD:2460 6480464 Benzoapyrene affects the expression of CYP1B1 mRNA CTD PMID:27099206 benzo[a]pyrene decreases expression ISO RGD:10439 6480464 Benzoapyrene results in decreased expression of CYP1B1 mRNA CTD PMID:26496743 benzo[a]pyrene affects metabolic processing ISO RGD:2460 6480464 CYP1B1 affects the metabolism of Benzoapyrene CTD PMID:24025706 benzo[a]pyrene increases expression ISO RGD:10439 6480464 Benzoapyrene results in increased expression of CYP1B1 mRNA, Benzoapyrene results in increased expression of CYP1B1 protein CTD PMID:11577022 more ... benzo[a]pyrene increases activity EXP 6480464 Benzoapyrene results in increased activity of CYP1B1 protein CTD PMID:15905203 , PMID:16484233 benzo[a]pyrene increases response to substance ISO RGD:10439 6480464 CYP1B1 protein results in increased susceptibility to Benzoapyrene CTD PMID:21252291 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene analog results in increased expression of CYP1B1 mRNA more ... CTD PMID:11854143 more ... benzo[a]pyrene decreases expression ISO RGD:2460 6480464 Benzoapyrene results in decreased expression of CYP1B1 mRNA CTD PMID:21839799 benzo[a]pyrene increases activity ISO RGD:2460 6480464 Benzoapyrene results in increased activity of CYP1B1 protein CTD PMID:15315710 , PMID:19497421 benzo[a]pyrene affects expression ISO RGD:10439 6480464 Benzoapyrene affects the expression of CYP1B1 mRNA CTD PMID:15037607 benzo[a]pyrene increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of Benzoapyrene CTD PMID:19879933 , PMID:32553695 benzo[a]pyrene decreases metabolic processing EXP 6480464 CYP1B1 protein polymorphism results in decreased metabolism of Benzoapyrene CTD PMID:15958554 benzo[a]pyrene increases hydrolysis EXP 6480464 CYP1B1 protein results in increased hydrolysis of Benzoapyrene CTD PMID:19919601 benzo[a]pyrene affects expression EXP 6480464 Benzoapyrene affects the expression of CYP1B1 mRNA CTD PMID:20624995 benzo[a]pyrene multiple interactions ISO RGD:10439 6480464 [1-methylanthracene co-treated with fluoranthene co-treated with Benzoapyrene] results in increased expression of CYP1B1 mRNA more ... CTD PMID:11577022 more ... benzo[a]pyrene increases expression ISO RGD:2460 6480464 Benzoapyrene results in increased expression of CYP1B1 mRNA, Benzoapyrene results in increased expression of CYP1B1 protein CTD PMID:15315710 more ... benzo[a]pyrene multiple interactions ISO RGD:2460 6480464 1 more ... CTD PMID:15315710 more ... benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I multiple interactions EXP 6480464 NADP promotes the reaction [CYP1B1 protein affects the chemical synthesis of 7 more ... CTD PMID:15720144 benzo[a]pyrene diol epoxide I affects chemical synthesis EXP 6480464 CYP1B1 protein affects the chemical synthesis of 7 more ... CTD PMID:15720144 , PMID:15958554 benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:17944540 more ... benzo[a]pyrene diol epoxide I decreases chemical synthesis EXP 6480464 CYP1B1 protein polymorphism results in decreased chemical synthesis of 7 more ... CTD PMID:15958554 Benzo[a]pyrene-7,8-diol multiple interactions EXP 6480464 benzoapyrene 7 more ... CTD PMID:15720144 more ... Benzo[a]pyrene-7,8-diol affects metabolic processing ISO RGD:2460 6480464 CYP1B1 affects the metabolism of benzoapyrene 7, 8-dihydrodiol CTD PMID:24025706 Benzo[a]pyrene-7,8-diol increases chemical synthesis EXP 6480464 CYP1B1 protein results in increased chemical synthesis of benzoapyrene 7, 8-dihydrodiol CTD PMID:19879933 Benzo[a]pyrene-7,8-diol increases expression EXP 6480464 benzoapyrene 7, 8-dihydrodiol results in increased expression of CYP1B1 mRNA CTD PMID:21028851 Benzo[a]pyrene-7,8-diol increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of benzoapyrene 7, 8-dihydrodiol CTD PMID:15861043 benzo[a]pyrene-7,8-dione multiple interactions EXP 6480464 benzoapyrene-7, 8-dione results in increased expression of and results in increased activity of CYP1B1 protein CTD PMID:16411658 benzo[a]pyrene-7,8-dione increases expression EXP 6480464 benzoapyrene-7, 8-dione results in increased expression of CYP1B1 mRNA CTD PMID:16411658 benzo[b]fluoranthene multiple interactions EXP 6480464 [phenanthrene co-treated with pyrene co-treated with Benzoapyrene co-treated with benzokfluoranthene co-treated with dibenzoa, lpyrene co-treated with benzobfluoranthene] results in increased expression of CYP1B1 mRNA CTD PMID:15566942 benzo[b]fluoranthene multiple interactions ISO RGD:10439 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of CYP1B1 mRNA CTD PMID:27858113 benzo[b]fluoranthene affects expression ISO RGD:2460 6480464 benzobfluoranthene affects the expression of CYP1B1 mRNA CTD PMID:27099206 benzo[b]fluoranthene multiple interactions ISO RGD:2460 6480464 benzobfluoranthene affects the reaction [Benzoapyrene affects the expression of CYP1B1 mRNA] CTD PMID:27099206 benzo[b]fluoranthene increases expression ISO RGD:10439 6480464 benzobfluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:12117779 , PMID:26377693 benzo[b]fluoranthene increases expression EXP 6480464 benzobfluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:27196671 benzo[b]fluoranthene increases expression ISO RGD:2460 6480464 benzobfluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:17961608 benzo[c]phenanthrene increases expression EXP 6480464 benzocphenanthrene results in increased expression of CYP1B1 protein CTD PMID:9168260 benzo[c]phenanthrene multiple interactions EXP 6480464 [[benzocphenanthrene results in increased expression of CYP1B1 protein] promotes the reaction [CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:9168260 benzo[e]pyrene increases expression ISO RGD:10439 6480464 benzoepyrene results in increased expression of CYP1B1 mRNA CTD PMID:12117779 benzo[e]pyrene increases expression EXP 6480464 benzoepyrene results in increased expression of CYP1B1 mRNA CTD PMID:27196671 Benzo[ghi]perylene multiple interactions EXP 6480464 [CYP1B1 protein results in increased oxidation of 1 more ... CTD PMID:23879290 Benzo[ghi]perylene increases expression EXP 6480464 1, 12-benzoperylene results in increased expression of CYP1B1 mRNA CTD PMID:27196671 Benzo[ghi]perylene increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of 1, 12-benzoperylene CTD PMID:23879290 Benzo[j]fluoranthene increases expression EXP 6480464 benzojfluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:27196671 Benzo[k]fluoranthene increases expression EXP 6480464 benzokfluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:15566942 more ... Benzo[k]fluoranthene increases expression ISO RGD:10439 6480464 benzokfluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases hydroxylation EXP 6480464 CYP1B1 protein results in increased hydroxylation of benzokfluoranthene CTD PMID:17919675 Benzo[k]fluoranthene multiple interactions EXP 6480464 [phenanthrene co-treated with pyrene co-treated with Benzoapyrene co-treated with benzokfluoranthene co-treated with dibenzoa more ... CTD PMID:15566942 , PMID:17919675 bergomottin multiple interactions EXP 6480464 bergamottin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzoapyrene 7, 8-dihydrodiol] CTD PMID:15861043 bergomottin decreases activity EXP 6480464 bergamottin results in decreased activity of CYP1B1 protein, bergamottin results in decreased activity of CYP1B1 protein polymorphism CTD PMID:15861043 beta-carboline multiple interactions EXP 6480464 CYP1B1 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 beta-naphthoflavone multiple interactions EXP 6480464 beta-Naphthoflavone binds to and results in decreased activity of CYP1B1 protein CTD PMID:19563207 , PMID:21053930 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP1B1 mRNA CTD PMID:12623754 more ... beta-naphthoflavone multiple interactions ISO RGD:10439 6480464 andrographolide promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA] more ... CTD PMID:19737545 more ... beta-naphthoflavone multiple interactions ISO RGD:2460 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1B1 mRNA CTD PMID:18164116 , PMID:20045035 beta-naphthoflavone increases expression ISO RGD:2460 6480464 beta-Naphthoflavone results in increased expression of CYP1B1 mRNA, beta-Naphthoflavone results in increased expression of CYP1B1 protein CTD PMID:19389873 more ... beta-naphthoflavone increases expression ISO RGD:10439 6480464 beta-Naphthoflavone results in increased expression of CYP1B1 mRNA CTD PMID:19737545 more ... bexarotene increases expression ISO RGD:2460 6480464 bexarotene results in increased expression of CYP1B1 mRNA CTD PMID:16648578 biochanin A increases expression EXP 6480464 biochanin A results in increased expression of CYP1B1 mRNA CTD PMID:28985473 , PMID:31621310 biochanin A multiple interactions EXP 6480464 AHR protein affects the reaction [biochanin A results in increased expression of CYP1B1 mRNA] more ... CTD PMID:31621310 biochanin A multiple interactions ISO RGD:10439 6480464 Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 biochanin A increases expression ISO RGD:10439 6480464 biochanin A results in increased expression of CYP1B1 mRNA CTD PMID:31621310 biochanin A decreases methylation EXP 6480464 CYP1B1 protein results in decreased methylation of biochanin A CTD PMID:15479032 biotin multiple interactions EXP 6480464 Biotin results in increased expression of and results in increased activity of CYP1B1 protein CTD PMID:15333708 biotin increases expression EXP 6480464 Biotin results in increased expression of CYP1B1 mRNA CTD PMID:15219929 , PMID:15333708 biphenyl multiple interactions EXP 6480464 diphenyl binds to and results in decreased activity of CYP1B1 protein CTD PMID:19563207 bis(2-chloroethyl) sulfide increases expression ISO RGD:10439 6480464 Mustard Gas results in increased expression of CYP1B1 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP1B1 mRNA CTD PMID:16040568 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:10439 6480464 Diethylhexyl Phthalate results in decreased expression of CYP1B1 mRNA CTD PMID:31211961 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 Diethylhexyl Phthalate results in increased expression of and results in increased activity of CYP1B1 protein CTD PMID:16040568 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP1B1 mRNA CTD PMID:20170705 bisphenol A multiple interactions ISO RGD:10439 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of CYP1B1 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:10439 6480464 bisphenol A results in increased expression of CYP1B1 mRNA CTD PMID:25594700 , PMID:30951980 bisphenol A increases expression ISO RGD:2460 6480464 bisphenol A results in increased expression of CYP1B1 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP1B1 mRNA CTD PMID:16474171 more ... bisphenol A decreases expression ISO RGD:10439 6480464 bisphenol A results in decreased expression of CYP1B1 mRNA CTD PMID:22687993 , PMID:23928317 bisphenol A multiple interactions EXP 6480464 bisphenol A results in increased expression of and affects the localization of CYP1B1 protein more ... CTD PMID:23524099 , PMID:29275510 bisphenol A decreases expression ISO RGD:2460 6480464 bisphenol A results in decreased expression of CYP1B1 mRNA, bisphenol A results in decreased expression of CYP1B1 protein CTD PMID:12075121 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP1B1 mRNA CTD PMID:16474171 bisphenol F multiple interactions ISO RGD:10439 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of CYP1B1 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:10439 6480464 bisphenol F results in increased expression of CYP1B1 mRNA CTD PMID:30951980 brefeldin A multiple interactions EXP 6480464 Brefeldin A inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:22167199 bucladesine increases expression ISO RGD:10439 6480464 Bucladesine results in increased expression of CYP1B1 mRNA CTD PMID:11559018 butan-1-ol multiple interactions EXP 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CYP1B1 mRNA CTD PMID:29432896 Butylbenzyl phthalate multiple interactions EXP 6480464 3' more ... CTD PMID:22138065 Butylbenzyl phthalate increases expression EXP 6480464 butylbenzyl phthalate results in increased expression of CYP1B1 mRNA, butylbenzyl phthalate results in increased expression of CYP1B1 protein CTD PMID:22138065 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of CYP1B1 mRNA CTD PMID:23524099 Butylparaben multiple interactions EXP 6480464 butylparaben promotes the reaction [bisphenol A results in increased expression of CYP1B1 mRNA] CTD PMID:23524099 butyric acid multiple interactions ISO RGD:10439 6480464 Butyric Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 butyric acid multiple interactions EXP 6480464 Butyric Acid promotes the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] more ... CTD PMID:27830268 more ... C60 fullerene decreases expression ISO RGD:2460 6480464 fullerene C60 results in decreased expression of CYP1B1 mRNA CTD PMID:19167457 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP1B1 mRNA CTD PMID:29741670 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CYP1B1 mRNA CTD PMID:12760830 , PMID:18560533 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP1B1 mRNA CTD PMID:29741670 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of CYP1B1 mRNA CTD PMID:25596134 cadmium dichloride decreases expression ISO RGD:10439 6480464 Cadmium Chloride results in decreased expression of CYP1B1 mRNA CTD PMID:11958953 caffeine decreases activity ISO RGD:10439 6480464 Caffeine results in decreased activity of CYP1B1 protein CTD PMID:18420780 calciol multiple interactions EXP 6480464 [3 more ... CTD PMID:31820026 calcium atom multiple interactions EXP 6480464 Calcium promotes the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA], Calcium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:16237193 calcium atom multiple interactions ISO RGD:10439 6480464 Calcium deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:19782052 calcium(0) multiple interactions EXP 6480464 Calcium promotes the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA], Calcium promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:16237193 calcium(0) multiple interactions ISO RGD:10439 6480464 Calcium deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:19782052 calyculin a multiple interactions EXP 6480464 calyculin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:10696073 carbon monoxide multiple interactions ISO RGD:10439 6480464 Carbon Monoxide promotes the reaction [1-ethynylpyrene results in increased expression of CYP1B1 mRNA] CTD PMID:10581206 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of CYP1B1 mRNA CTD PMID:17450800 carbon nanotube increases expression ISO RGD:10439 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl sulfide increases expression ISO RGD:2460 6480464 carbonyl sulfide results in increased expression of CYP1B1 mRNA CTD PMID:19395590 Carnosol multiple interactions EXP 6480464 carnosol inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA], carnosol inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 protein] CTD PMID:22374940 cefaloridine increases expression ISO RGD:2460 6480464 Cephaloridine results in increased expression of CYP1B1 mRNA CTD PMID:18500788 ceric oxide affects expression ISO RGD:2460 6480464 ceric oxide affects the expression of CYP1B1 mRNA CTD PMID:29463257 chelerythrine multiple interactions ISO RGD:10439 6480464 chelerythrine inhibits the reaction [CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:10037446 chloroacetaldehyde affects expression EXP 6480464 chloroacetaldehyde affects the expression of CYP1B1 mRNA CTD PMID:25596134 chloropicrin affects expression EXP 6480464 chloropicrin affects the expression of CYP1B1 mRNA CTD PMID:26352163 chloropicrin increases expression EXP 6480464 chloropicrin results in increased expression of CYP1B1 mRNA CTD PMID:28476498 chloroprene increases expression ISO RGD:10439 6480464 Chloroprene results in increased expression of CYP1B1 mRNA CTD PMID:23125180 chlorpromazine decreases response to substance EXP 6480464 CYP1B1 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 chlorpromazine multiple interactions EXP 6480464 [Filipin co-treated with Chlorpromazine co-treated with Wortmannin] inhibits the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA] CTD PMID:29724254 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CYP1B1 mRNA CTD PMID:19326769 choline multiple interactions ISO RGD:10439 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP1B1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP1B1 gene CTD PMID:20938992 Chorionic gonadotropin decreases expression ISO RGD:2460 6480464 Chorionic Gonadotropin results in decreased expression of CYP1B1 mRNA CTD PMID:26923738 Chorionic gonadotropin multiple interactions ISO RGD:2460 6480464 Atrazine inhibits the reaction [Chorionic Gonadotropin results in decreased expression of CYP1B1 mRNA] CTD PMID:26923738 chromium atom decreases expression EXP 6480464 Chromium results in decreased expression of CYP1B1 mRNA CTD PMID:21437242 chromium(6+) multiple interactions ISO RGD:10439 6480464 [chromium hexavalent ion co-treated with Benzoapyrene] affects the expression of CYP1B1 mRNA CTD PMID:25820237 chromium(6+) decreases expression EXP 6480464 chromium hexavalent ion results in decreased expression of CYP1B1 mRNA CTD PMID:30690063 chrysene multiple interactions ISO RGD:2460 6480464 chrysene inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:15315710 chrysene multiple interactions ISO RGD:10439 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of CYP1B1 mRNA CTD PMID:27858113 chrysene increases expression EXP 6480464 chrysene results in increased expression of CYP1B1 mRNA, chrysene results in increased expression of CYP1B1 protein CTD PMID:12107646 more ... chrysene increases expression ISO RGD:2460 6480464 chrysene results in increased expression of CYP1B1 mRNA CTD PMID:17961608 chrysene increases expression ISO RGD:10439 6480464 chrysene results in increased expression of CYP1B1 mRNA CTD PMID:12117779 chrysin multiple interactions EXP 6480464 [CYP1B1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein, chrysin binds to and results in decreased activity of CYP1B1 protein CTD PMID:19666078 , PMID:21053930 chrysin increases oxidation EXP 6480464 CYP1B1 protein alternative form results in increased oxidation of chrysin CTD PMID:30964977 chrysin increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of chrysin CTD PMID:19666078 chrysin decreases activity EXP 6480464 chrysin results in decreased activity of CYP1B1 protein CTD PMID:21482471 chrysin 5,7-dimethyl ether multiple interactions EXP 6480464 5 more ... CTD PMID:16484233 , PMID:16530937 chrysin 5,7-dimethyl ether decreases activity EXP 6480464 5, 7-dimethoxyflavone results in decreased activity of CYP1B1 protein CTD PMID:15905203 chrysophanol decreases activity EXP 6480464 chrysophanic acid results in decreased activity of CYP1B1 protein CTD PMID:27633141 cidofovir anhydrous increases expression EXP 6480464 Cidofovir results in increased expression of CYP1B1 mRNA CTD PMID:25596134 cirsiliol decreases activity EXP 6480464 cirsiliol results in decreased activity of CYP1B1 protein CTD PMID:21482471 cirsiliol increases expression EXP 6480464 cirsiliol results in increased expression of CYP1B1 mRNA CTD PMID:19601638 cirsiliol increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of cirsiliol CTD PMID:19601638 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CYP1B1 mRNA CTD PMID:25596134 , PMID:27594783 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CYP1B1 mRNA CTD PMID:27392435 citral multiple interactions EXP 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral, [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite CTD PMID:18824010 clodronic acid increases expression EXP 6480464 Clodronic Acid results in increased expression of CYP1B1 mRNA CTD PMID:25596134 clothianidin multiple interactions EXP 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP1B1 protein CTD PMID:32201337 clozapine increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of Clozapine CTD PMID:18809730 cobalt atom multiple interactions EXP 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of CYP1B1 mRNA CTD PMID:18078969 cobalt dichloride multiple interactions EXP 6480464 cobaltous chloride inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:20228066 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CYP1B1 mRNA CTD PMID:19376846 colforsin daropate hydrochloride increases expression ISO RGD:2460 6480464 Colforsin results in increased expression of CYP1B1 mRNA, Colforsin results in increased expression of CYP1B1 protein CTD PMID:7588239 copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of CYP1B1 mRNA CTD PMID:20971185 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of CYP1B1 mRNA CTD PMID:20971185 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of CYP1B1 mRNA CTD PMID:12860252 , PMID:19549813 cortisol multiple interactions ISO RGD:2460 6480464 [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benzaanthracene results in increased expression of CYP1B1 protein] more ... CTD PMID:8674863 cortisol decreases expression ISO RGD:2460 6480464 Hydrocortisone results in decreased expression of CYP1B1 protein CTD PMID:8674863 coumestrol increases expression EXP 6480464 Coumestrol results in increased expression of CYP1B1 mRNA CTD PMID:19167446 coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CYP1B1 mRNA CTD PMID:19167446 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA], Curcumin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein] CTD PMID:19018768 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of CYP1B1 mRNA CTD PMID:17637178 cycloheximide increases expression EXP 6480464 Cycloheximide results in increased expression of CYP1B1 mRNA CTD PMID:19684285 cycloheximide multiple interactions ISO RGD:2460 6480464 Cycloheximide inhibits the reaction [Vehicle Emissions results in increased expression of CYP1B1 protein] CTD PMID:21867498 cycloheximide multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CYP1B1 mRNA, Cycloheximide inhibits the reaction [TGFB1 protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]] CTD PMID:19684285 , PMID:9145908 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of CYP1B1 mRNA CTD PMID:12167460 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CYP1B1 mRNA CTD PMID:20106945 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CYP1B1 mRNA CTD PMID:25596134 cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of CYP1B1 mRNA CTD PMID:23726867 cypermethrin decreases activity ISO RGD:10439 6480464 cypermethrin results in decreased activity of CYP1B1 protein CTD PMID:18420780 cypermethrin affects expression ISO RGD:10439 6480464 cypermethrin affects the expression of CYP1B1 mRNA CTD PMID:32214279 cypermethrin increases expression ISO RGD:10439 6480464 cypermethrin results in increased expression of CYP1B1 CTD PMID:32214279 D-glucose multiple interactions EXP 6480464 [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein], [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein CTD PMID:28400208 daidzein affects chemical synthesis EXP 6480464 CYP1B1 protein affects the chemical synthesis of daidzein CTD PMID:15479032 daidzein decreases activity ISO RGD:10439 6480464 daidzein results in decreased activity of CYP1B1 protein CTD PMID:18420780 daidzein decreases activity EXP 6480464 daidzein results in decreased activity of CYP1B1 protein CTD PMID:15479032 daunorubicin affects response to substance EXP 6480464 CYP1B1 affects the susceptibility to Daunorubicin CTD PMID:18451141 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP1B1 mRNA CTD PMID:16040568 DDT multiple interactions EXP 6480464 [indole-3-carbinol co-treated with DDT] results in increased expression of CYP1B1 mRNA CTD PMID:17311112 decabromodiphenyl ether multiple interactions ISO RGD:2460 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased expression of CYP1B1 mRNA CTD PMID:32207525 dehydroepiandrosterone multiple interactions ISO RGD:10439 6480464 Dehydroepiandrosterone inhibits the reaction [benzaanthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9 more ... CTD PMID:10497882 dehydroepiandrosterone increases expression ISO RGD:10439 6480464 Dehydroepiandrosterone results in increased expression of CYP1B1 mRNA CTD PMID:10497882 deoxynivalenol decreases expression EXP 6480464 deoxynivalenol results in decreased expression of CYP1B1 mRNA CTD PMID:20702593 dexamethasone multiple interactions ISO RGD:10439 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CYP1B1 mRNA, [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CYP1B1 protein CTD PMID:15967407 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of CYP1B1 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:10439 6480464 Dexamethasone results in increased expression of CYP1B1 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:2460 6480464 Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] more ... CTD PMID:17690134 , PMID:9804617 dextromethorphan decreases activity ISO RGD:10439 6480464 Dextromethorphan results in decreased activity of CYP1B1 protein CTD PMID:18420780 Diallyl sulfide increases expression ISO RGD:2460 6480464 allyl sulfide results in increased expression of CYP1B1 mRNA CTD PMID:17129689 Diallyl sulfide multiple interactions ISO RGD:2460 6480464 [Diethylstilbestrol co-treated with allyl sulfide] results in increased expression of CYP1B1 mRNA CTD PMID:17129689 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CYP1B1 protein CTD PMID:29876539 diarsenic trioxide multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYP1B1 mRNA, Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of CYP1B1 protein] CTD PMID:15894607 , PMID:29876539 diarsenic trioxide affects expression EXP 6480464 Arsenic Trioxide affects the expression of CYP1B1 mRNA CTD PMID:17530438 diazinon decreases expression ISO RGD:2460 6480464 Diazinon results in decreased expression of CYP1B1 mRNA CTD PMID:29108742 Dibenz[a,c]anthracene increases expression EXP 6480464 benzotriphenylene results in increased expression of CYP1B1 mRNA CTD PMID:17253728 dibenz[a,h]anthracene increases expression ISO RGD:2460 6480464 1 more ... CTD PMID:17961608 dibenz[a,h]anthracene affects expression ISO RGD:2460 6480464 1 more ... CTD PMID:27099206 dibenz[a,h]anthracene multiple interactions ISO RGD:2460 6480464 1 more ... CTD PMID:27099206 dibenz[a,h]anthracene increases expression ISO RGD:10439 6480464 1 more ... CTD PMID:12117779 , PMID:26377693 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:11955671 more ... Dibenzo[a,e]pyrene increases expression ISO RGD:2460 6480464 dibenzoa, epyrene results in increased expression of CYP1B1 mRNA CTD PMID:17961608 dibenzo[a,l]pyrene multiple interactions EXP 6480464 [Particulate Matter co-treated with dibenzoa more ... CTD PMID:15566942 , PMID:17612574 dibenzo[a,l]pyrene decreases expression EXP 6480464 dibenzoa, lpyrene results in decreased expression of CYP1B1 mRNA CTD PMID:31255691 dibenzo[a,l]pyrene affects expression ISO RGD:2460 6480464 dibenzoa, lpyrene affects the expression of CYP1B1 mRNA CTD PMID:27099206 dibenzo[a,l]pyrene decreases response to substance ISO RGD:10439 6480464 CYP1B1 gene mutant form results in decreased susceptibility to dibenzoa, lpyrene CTD PMID:26049101 dibenzo[a,l]pyrene decreases expression ISO RGD:10439 6480464 dibenzoa, lpyrene results in decreased expression of CYP1B1 mRNA CTD PMID:23274566 dibenzo[a,l]pyrene decreases activity ISO RGD:2460 6480464 [2 more ... CTD PMID:17961608 dibenzo[a,l]pyrene multiple interactions ISO RGD:2460 6480464 [2 more ... CTD PMID:17961608 , PMID:27099206 dibenzo[a,l]pyrene increases expression ISO RGD:10439 6480464 dibenzoa more ... CTD PMID:12117779 more ... dibenzo[a,l]pyrene multiple interactions ISO RGD:10439 6480464 dibenzoa more ... CTD PMID:17060372 dibenzo[a,l]pyrene increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of dibenzoa, lpyrene CTD PMID:21527924 dibenzo[a,l]pyrene increases expression EXP 6480464 dibenzoa, lpyrene results in increased expression of CYP1B1 mRNA CTD PMID:15566942 dibenzo[a,l]pyrene increases activity ISO RGD:10439 6480464 CYP1B1 protein results in increased activity of dibenzoa, lpyrene CTD PMID:15606143 dibromoacetic acid decreases expression ISO RGD:2460 6480464 dibromoacetic acid results in decreased expression of CYP1B1 mRNA CTD PMID:21046364 dibutyl phthalate multiple interactions EXP 6480464 Dibutyl Phthalate results in increased expression of and results in increased activity of CYP1B1 protein CTD PMID:16040568 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP1B1 mRNA CTD PMID:16040568 dichloromethane decreases expression EXP 6480464 Methylene Chloride results in decreased expression of CYP1B1 mRNA CTD PMID:20359517 diclofenac decreases activity ISO RGD:10439 6480464 Diclofenac results in decreased activity of CYP1B1 protein CTD PMID:18420780 dieldrin increases expression ISO RGD:2460 6480464 Dieldrin results in increased expression of CYP1B1 mRNA CTD PMID:10910964 diethyl phthalate multiple interactions EXP 6480464 diethyl phthalate results in increased expression of and results in increased activity of CYP1B1 protein CTD PMID:16040568 diethyl phthalate increases expression EXP 6480464 diethyl phthalate results in increased expression of CYP1B1 mRNA CTD PMID:16040568 diethylstilbestrol multiple interactions ISO RGD:2460 6480464 [Diethylstilbestrol co-treated with allyl sulfide] results in increased expression of CYP1B1 mRNA CTD PMID:17129689 diethylstilbestrol decreases expression ISO RGD:2460 6480464 Diethylstilbestrol results in decreased expression of CYP1B1 mRNA CTD PMID:21658437 diethylstilbestrol increases expression ISO RGD:10439 6480464 Diethylstilbestrol results in increased expression of CYP1B1 mRNA CTD PMID:21041162 diethylstilbestrol increases expression ISO RGD:2460 6480464 Diethylstilbestrol results in increased expression of CYP1B1 mRNA CTD PMID:17129689 dihydroergotamine decreases activity ISO RGD:10439 6480464 Dihydroergotamine results in decreased activity of CYP1B1 protein CTD PMID:18420780 dimethyl sulfoxide affects expression EXP 6480464 Dimethyl Sulfoxide affects the expression of CYP1B1 mRNA CTD PMID:12843640 diosmetin decreases activity EXP 6480464 diosmetin results in decreased activity of CYP1B1 protein CTD PMID:10781868 , PMID:21482471 dioxygen multiple interactions EXP 6480464 [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein] more ... CTD PMID:24355420 , PMID:28400208 dioxygen increases expression ISO RGD:10439 6480464 Oxygen results in increased expression of CYP1B1 mRNA CTD PMID:29939353 dioxygen decreases response to substance ISO RGD:10439 6480464 CYP1B1 gene mutant form results in decreased susceptibility to Oxygen CTD PMID:29939353 dioxygen multiple interactions ISO RGD:10439 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP1B1 mRNA more ... CTD PMID:29432836 more ... dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of CYP1B1 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:2460 6480464 [Benzoapyrene co-treated with Oxygen] affects the expression of CYP1B1 protein CTD PMID:24657529 diuron decreases expression ISO RGD:2460 6480464 Diuron results in decreased expression of CYP1B1 mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of CYP1B1 mRNA CTD PMID:24172598 diuron increases expression ISO RGD:2460 6480464 Diuron results in increased expression of CYP1B1 mRNA CTD PMID:21551480 dopamine decreases activity ISO RGD:10439 6480464 Dopamine results in decreased activity of CYP1B1 protein CTD PMID:18420780 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:2460 6480464 Doxorubicin results in increased expression of CYP1B1 mRNA, Doxorubicin results in increased expression of CYP1B1 protein CTD PMID:19796650 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CYP1B1 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:10439 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of CYP1B1 mRNA CTD PMID:21040762 doxorubicin increases expression ISO RGD:10439 6480464 Doxorubicin results in increased expression of CYP1B1 mRNA CTD PMID:21040762 , PMID:28608983 doxycycline increases expression EXP 6480464 [Doxycycline results in increased expression of AHR protein] which results in increased expression of CYP1B1 mRNA CTD PMID:22273977 doxycycline multiple interactions EXP 6480464 [[Doxycycline results in increased expression of AHR protein] which co-treated with Tobacco Smoke Pollution] results in increased expression of CYP1B1 mRNA CTD PMID:22273977 Droloxifene decreases activity EXP 6480464 droloxifene results in decreased activity of CYP1B1 protein CTD PMID:12419016 ellagic acid multiple interactions ISO RGD:10439 6480464 [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9 more ... CTD PMID:20103723 ellagic acid decreases activity ISO RGD:10439 6480464 Ellagic Acid results in decreased activity of CYP1B1 protein CTD PMID:19329757 ellipticine increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of ellipticine CTD PMID:22917556 ellipticine multiple interactions ISO RGD:10439 6480464 ellipticine inhibits the reaction [AHR protein promotes the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA]] CTD PMID:11577022 emodin increases expression EXP 6480464 Emodin results in increased expression of CYP1B1 mRNA, Emodin results in increased expression of CYP1B1 protein CTD PMID:11502733 , PMID:14990334 emodin decreases activity EXP 6480464 Emodin results in decreased activity of CYP1B1 protein CTD PMID:27633141 enilconazole increases expression EXP 6480464 enilconazole results in increased expression of CYP1B1 mRNA CTD PMID:32201337 enilconazole multiple interactions EXP 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP1B1 protein CTD PMID:32201337 estrone increases hydroxylation EXP 6480464 CYP1B1 protein results in increased hydroxylation of Estrone CTD PMID:15763594 estrone affects binding EXP 6480464 CYP1B1 protein binds to Estrone CTD PMID:27966929 estrone multiple interactions EXP 6480464 Estrone binds to and results in decreased activity of CYP1B1 protein CTD PMID:19563207 estrone affects hydroxylation EXP 6480464 CYP1B1 protein polymorphism affects the hydroxylation of Estrone CTD PMID:16207128 ethanol multiple interactions ISO RGD:10439 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYP1B1 mRNA more ... CTD PMID:22486318 , PMID:30517762 ethanol multiple interactions EXP 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CYP1B1 mRNA CTD PMID:29432896 ethanol increases expression ISO RGD:2460 6480464 Ethanol results in increased expression of CYP1B1 mRNA CTD PMID:23273579 ethanol increases expression ISO RGD:10439 6480464 Ethanol results in increased expression of CYP1B1 mRNA CTD PMID:22486318 ethoxyquin increases expression ISO RGD:2460 6480464 Ethoxyquin results in increased expression of CYP1B1 mRNA CTD PMID:19695238 ethylbenzene decreases expression EXP 6480464 ethylbenzene results in decreased expression of CYP1B1 mRNA CTD PMID:20359517 ethylisopropylamiloride decreases activity EXP 6480464 ethylisopropylamiloride results in decreased activity of CYP1B1 protein CTD PMID:15081870 eugenol decreases activity EXP 6480464 Eugenol results in decreased activity of CYP1B1 protein CTD PMID:17275817 eugenol multiple interactions EXP 6480464 Eugenol inhibits the reaction [9 more ... CTD PMID:17275817 eupatorin increases expression EXP 6480464 eupatorin results in increased expression of CYP1B1 mRNA CTD PMID:19601638 eupatorin decreases activity EXP 6480464 eupatorin results in decreased activity of CYP1B1 protein CTD PMID:21482471 eupatorin increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of eupatorin analog CTD PMID:21482471 filipin III multiple interactions EXP 6480464 [Filipin co-treated with Chlorpromazine co-treated with Wortmannin] inhibits the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA] CTD PMID:29724254 fingolimod hydrochloride decreases expression EXP 6480464 Fingolimod Hydrochloride results in decreased expression of CYP1B1 mRNA CTD PMID:29654831 flavanone multiple interactions EXP 6480464 flavanone binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 flavanone increases expression ISO RGD:10439 6480464 flavanone analog results in increased expression of CYP1B1 mRNA CTD PMID:31621310 flavone increases expression EXP 6480464 flavone results in increased expression of CYP1B1 mRNA CTD PMID:15890477 flavone multiple interactions EXP 6480464 flavone binds to and results in decreased activity of CYP1B1 protein CTD PMID:19563207 , PMID:21053930 flavonol multiple interactions EXP 6480464 3-hydroxyflavone binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 fluoranthene decreases activity ISO RGD:2460 6480464 [fluoranthene results in decreased activity of CYP1B1 protein] which results in decreased activity of dibenzoa, lpyrene CTD PMID:17961608 fluoranthene multiple interactions ISO RGD:10439 6480464 [1-methylanthracene co-treated with fluoranthene co-treated with Benzoapyrene] results in increased expression of CYP1B1 mRNA, [1-methylanthracene co-treated with fluoranthene] results in increased expression of CYP1B1 mRNA CTD PMID:28329830 , PMID:29170806 fluoranthene increases expression ISO RGD:10439 6480464 fluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:28329830 fluoranthene affects expression ISO RGD:2460 6480464 fluoranthene affects the expression of CYP1B1 mRNA CTD PMID:27099206 fluoranthene increases expression ISO RGD:2460 6480464 fluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:25268939 fluoranthene increases expression EXP 6480464 fluoranthene results in increased expression of CYP1B1 mRNA CTD PMID:27196671 fluoranthene multiple interactions ISO RGD:2460 6480464 [fluoranthene results in decreased activity of CYP1B1 protein] which results in decreased susceptibility to dibenzoa more ... CTD PMID:17961608 more ... flutamide increases expression ISO RGD:2460 6480464 Flutamide results in increased expression of CYP1B1 mRNA CTD PMID:21525395 , PMID:26485406 folic acid multiple interactions ISO RGD:10439 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP1B1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP1B1 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:10439 6480464 Folic Acid results in decreased expression of CYP1B1 mRNA CTD PMID:25629700 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of CYP1B1 mRNA CTD PMID:20655997 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of CYP1B1 mRNA CTD PMID:28937961 formaldehyde increases expression ISO RGD:2460 6480464 Formaldehyde results in increased expression of CYP1B1 mRNA CTD PMID:12679049 formononetin decreases methylation EXP 6480464 CYP1B1 protein results in decreased methylation of formononetin CTD PMID:15479032 formononetin increases expression EXP 6480464 formononetin results in increased expression of CYP1B1 mRNA CTD PMID:28985473 fructose multiple interactions ISO RGD:10439 6480464 [Dietary Fats co-treated with Fructose] results in increased expression of CYP1B1 mRNA more ... CTD PMID:26102010 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [2-amino-1-methyl-6-phenylimidazo4 more ... CTD PMID:19460354 more ... fulvestrant increases expression EXP 6480464 fulvestrant results in increased expression of CYP1B1 mRNA CTD PMID:28985473 fulvestrant multiple interactions ISO RGD:10439 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of CYP1B1 mRNA] CTD PMID:16280380 fumonisin B1 increases expression EXP 6480464 fumonisin B1 results in increased expression of CYP1B1 mRNA, fumonisin B1 results in increased expression of CYP1B1 protein CTD PMID:24614526 furan increases expression ISO RGD:2460 6480464 furan results in increased expression of CYP1B1 mRNA CTD PMID:27387713 galangin multiple interactions EXP 6480464 galangin binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 gamma-hexachlorocyclohexane decreases expression ISO RGD:2460 6480464 Hexachlorocyclohexane results in decreased expression of CYP1B1 mRNA CTD PMID:17785943 genistein affects chemical synthesis EXP 6480464 CYP1B1 protein affects the chemical synthesis of Genistein CTD PMID:15479032 genistein decreases expression ISO RGD:10439 6480464 Genistein results in decreased expression of CYP1B1 mRNA CTD PMID:32186404 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CYP1B1 mRNA CTD PMID:15257099 more ... genistein increases expression EXP 6480464 Genistein results in increased expression of CYP1B1 mRNA CTD PMID:16474171 , PMID:23524099 genistein multiple interactions EXP 6480464 Genistein binds to and results in decreased activity of CYP1B1 protein, triclocarban promotes the reaction [Genistein results in increased expression of CYP1B1 mRNA] CTD PMID:21053930 , PMID:23524099 genistein decreases expression ISO RGD:2460 6480464 Genistein results in decreased expression of CYP1B1 mRNA CTD PMID:12075121 genistein decreases activity EXP 6480464 Genistein results in decreased activity of CYP1B1 protein CTD PMID:15479032 genkwanin increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of genkwanin CTD PMID:19666078 genkwanin multiple interactions EXP 6480464 [CYP1B1 protein results in increased metabolism of genkwanin] which results in increased chemical synthesis of Apigenin CTD PMID:19666078 gentamycin increases expression ISO RGD:2460 6480464 Gentamicins results in increased expression of CYP1B1 mRNA CTD PMID:18172885 geranial multiple interactions EXP 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral, [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral metabolite CTD PMID:18824010 geraniol multiple interactions EXP 6480464 [[CYP1A1 protein co-treated with CYP1B1 protein co-treated with CYP2B6 protein co-treated with CYP2E1 protein co-treated with CYP3A5 protein] results in increased metabolism of geraniol] which results in increased chemical synthesis of citral more ... CTD PMID:18824010 glucaric acid multiple interactions ISO RGD:10439 6480464 [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9 more ... CTD PMID:20103723 glucoerucin increases expression ISO RGD:2460 6480464 glucoerucin results in increased expression of CYP1B1 protein CTD PMID:20833222 glucoerucin(1-) increases expression ISO RGD:2460 6480464 glucoerucin results in increased expression of CYP1B1 protein CTD PMID:20833222 glucoraphanin increases expression ISO RGD:2460 6480464 glucoraphanin results in increased expression of CYP1B1 protein CTD PMID:20833222 glucose multiple interactions EXP 6480464 [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein], [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein CTD PMID:28400208 glutathione multiple interactions EXP 6480464 [CYP1B1 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-glutathion-S-yl-deschlorodiclofenac more ... CTD PMID:14679015 , PMID:24246759 hesperetin decreases activity EXP 6480464 hesperetin results in decreased activity of CYP1B1 protein CTD PMID:10781868 hexachlorobenzene increases expression ISO RGD:2460 6480464 Hexachlorobenzene results in increased expression of CYP1B1 mRNA CTD PMID:15159207 homoeriodictyol decreases activity EXP 6480464 homoeriodictyol results in decreased activity of CYP1B1 protein CTD PMID:10781868 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of CYP1B1 mRNA CTD PMID:20044591 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of CYP1B1 mRNA CTD PMID:12414654 , PMID:25460656 hydrogen sulfide increases expression ISO RGD:10439 6480464 Hydrogen Sulfide results in increased expression of CYP1B1 mRNA CTD PMID:31843631 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of CYP1B1 mRNA CTD PMID:23416264 , PMID:31256213 ICI 118551 multiple interactions EXP 6480464 ICI 118551 inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:22167199 ifosfamide decreases expression EXP 6480464 Ifosfamide results in decreased expression of CYP1B1 mRNA CTD PMID:25596134 imperatorin decreases activity EXP 6480464 imperatorin results in decreased activity of CYP1B1 protein, imperatorin results in decreased activity of CYP1B1 protein polymorphism CTD PMID:15861043 imperatorin multiple interactions EXP 6480464 imperatorin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzoapyrene 7, 8-dihydrodiol] CTD PMID:15861043 Indeno[1,2,3-cd]pyrene increases expression EXP 6480464 indeno1 more ... CTD PMID:17253728 , PMID:27196671 indole-3-acetic acid increases expression EXP 6480464 indoleacetic acid results in increased expression of CYP1B1 mRNA CTD PMID:30324315 indole-3-acetic acid multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid 2-methyl-4-o-tolylazophenylamide inhibits the reaction [indoleacetic acid results in increased expression of CYP1B1 mRNA], indoleacetic acid promotes the reaction [AHR protein binds to CYP1B1 promoter] CTD PMID:30324315 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with DDT] results in increased expression of CYP1B1 mRNA CTD PMID:17311112 indole-3-methanol multiple interactions ISO RGD:2460 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA, Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA] CTD PMID:22129741 indole-3-methanol affects expression ISO RGD:2460 6480464 indole-3-carbinol affects the expression of CYP1B1 mRNA CTD PMID:21396975 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of CYP1B1 mRNA CTD PMID:15890477 , PMID:17311112 indole-3-methanol increases expression ISO RGD:2460 6480464 indole-3-carbinol results in increased expression of CYP1B1 mRNA CTD PMID:12147290 indoles affects response to substance EXP 6480464 CYP1B1 protein polymorphism affects the susceptibility to Indoles CTD PMID:16207128 indometacin increases expression ISO RGD:2460 6480464 Indomethacin results in increased expression of CYP1B1 mRNA CTD PMID:16184411 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in decreased expression of CYP1B1 mRNA CTD PMID:28628672 indoxyl sulfate increases expression EXP 6480464 Indican results in increased expression of CYP1B1 mRNA CTD PMID:20000589 isoflavones increases expression ISO RGD:10439 6480464 Isoflavones analog results in increased expression of CYP1B1 mRNA CTD PMID:31621310 isoflavones multiple interactions ISO RGD:10439 6480464 AHR protein affects the reaction [Isoflavones analog results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 isoimperatorin multiple interactions EXP 6480464 isoimperatorin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzoapyrene 7, 8-dihydrodiol] CTD PMID:15861043 isoimperatorin decreases activity EXP 6480464 isoimperatorin results in decreased activity of CYP1B1 protein, isoimperatorin results in decreased activity of CYP1B1 protein polymorphism CTD PMID:15861043 isoliquiritigenin multiple interactions EXP 6480464 isoliquiritigenin inhibits the reaction [9 more ... CTD PMID:25110319 , PMID:26134484 isoliquiritigenin increases expression EXP 6480464 isoliquiritigenin results in increased expression of CYP1B1 mRNA CTD PMID:26134484 isopimpinellin multiple interactions EXP 6480464 isopimpinellin inhibits the reaction [CYP1B1 protein results in increased oxidation of benzoapyrene 7, 8-dihydrodiol] CTD PMID:15861043 isopimpinellin decreases activity EXP 6480464 isopimpinellin results in decreased activity of CYP1B1 protein, isopimpinellin results in decreased activity of CYP1B1 protein polymorphism CTD PMID:15861043 isoprenaline increases expression ISO RGD:2460 6480464 Isoproterenol results in increased expression of CYP1B1 mRNA CTD PMID:18725507 isoprenaline increases expression ISO RGD:10439 6480464 Isoproterenol results in increased expression of CYP1B1 mRNA CTD PMID:20003209 isoproturon decreases activity ISO RGD:10439 6480464 isoproturon results in decreased activity of CYP1B1 protein CTD PMID:18420780 isorhamnetin decreases expression EXP 6480464 3-methylquercetin results in decreased expression of CYP1B1 mRNA CTD PMID:19794518 ivermectin decreases activity ISO RGD:10439 6480464 Ivermectin results in decreased activity of CYP1B1 protein CTD PMID:18420780 kaempferol decreases expression EXP 6480464 kaempferol results in decreased expression of CYP1B1 mRNA CTD PMID:19794518 kaempferol multiple interactions EXP 6480464 kaempferol binds to and results in decreased activity of CYP1B1 protein more ... CTD PMID:20846786 , PMID:21053930 kaempferol decreases activity EXP 6480464 kaempferol results in decreased activity of CYP1B1 protein CTD PMID:16271822 , PMID:21482471 ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP1B1 protein CTD PMID:14709627 ketoconazole decreases activity ISO RGD:10439 6480464 Ketoconazole results in decreased activity of CYP1B1 protein CTD PMID:18420780 KN-93 multiple interactions EXP 6480464 KN 93 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:18089838 L-methionine multiple interactions ISO RGD:10439 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYP1B1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP1B1 gene CTD PMID:20938992 lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP1B1 mRNA CTD PMID:12623754 laquinimod increases expression ISO RGD:2460 6480464 laquinimod analog results in increased expression of CYP1B1 mRNA, laquinimod metabolite results in increased expression of CYP1B1 mRNA CTD PMID:28433708 , PMID:32668270 laquinimod increases expression EXP 6480464 laquinimod metabolite results in increased expression of CYP1B1 mRNA CTD PMID:32668270 laquinimod multiple interactions EXP 6480464 Progesterone promotes the reaction [laquinimod metabolite results in increased expression of CYP1B1 mRNA] CTD PMID:32668270 lead diacetate increases expression ISO RGD:2460 6480464 lead acetate results in increased expression of CYP1B1 mRNA CTD PMID:22641619 leflunomide increases expression ISO RGD:2460 6480464 leflunomide results in increased expression of CYP1B1 mRNA CTD PMID:24136188 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CYP1B1 mRNA CTD PMID:28988120 linuron increases expression EXP 6480464 Linuron results in increased expression of CYP1B1 mRNA CTD PMID:16040568 linuron multiple interactions ISO RGD:10439 6480464 XBP1 gene promotes the reaction [Linuron results in increased expression of CYP1B1 mRNA] CTD PMID:30661753 linuron increases expression ISO RGD:10439 6480464 Linuron results in increased expression of CYP1B1 mRNA CTD PMID:30661753 lithocholic acid decreases activity ISO RGD:10439 6480464 Lithocholic Acid results in decreased activity of CYP1B1 protein CTD PMID:18420780 luteolin decreases activity EXP 6480464 Luteolin results in decreased activity of CYP1B1 protein CTD PMID:21482471 luteolin increases expression EXP 6480464 Luteolin results in increased expression of CYP1B1 mRNA CTD PMID:23994263 LY294002 multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 mRNA], 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 protein] CTD PMID:20093341 lycopene decreases activity ISO RGD:10439 6480464 lycopene results in decreased activity of CYP1B1 protein CTD PMID:19329757 lycopene multiple interactions ISO RGD:10439 6480464 lycopene affects the reaction [Atrazine results in increased expression of CYP1B1 mRNA] CTD PMID:26775023 medroxyprogesterone acetate multiple interactions EXP 6480464 CYP1B1 gene polymorphism affects the susceptibility to [Estrogens co-treated with Medroxyprogesterone Acetate] CTD PMID:15987428 MeIQx affects response to substance EXP 6480464 CYP1B1 protein affects the susceptibility to 2-amino-3 more ... CTD PMID:19223546 MeIQx increases expression EXP 6480464 2-amino-3 more ... CTD PMID:20307560 , PMID:20816883 MeIQx multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo4 more ... CTD PMID:20307560 melatonin multiple interactions EXP 6480464 2 more ... CTD PMID:15616152 melatonin decreases activity EXP 6480464 Melatonin results in decreased activity of CYP1B1 protein CTD PMID:19919601 melatonin increases hydroxylation EXP 6480464 CYP1B1 protein results in increased hydroxylation of Melatonin CTD PMID:15616152 menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of CYP1B1 mRNA CTD PMID:12414654 mephenytoin decreases activity ISO RGD:10439 6480464 Mephenytoin results in decreased activity of CYP1B1 protein CTD PMID:18420780 mercury atom multiple interactions ISO RGD:10439 6480464 Mercury affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] more ... CTD PMID:22579925 , PMID:23231920 mercury atom increases expression ISO RGD:10439 6480464 Mercury results in increased expression of CYP1B1 protein CTD PMID:22579925 , PMID:23231920 mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of CYP1B1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP1B1 mRNA CTD PMID:27188386 mercury dichloride increases expression ISO RGD:10439 6480464 Mercuric Chloride results in increased expression of CYP1B1 mRNA CTD PMID:21435368 , PMID:24472606 mercury(0) multiple interactions ISO RGD:10439 6480464 Mercury affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] more ... CTD PMID:22579925 , PMID:23231920 mercury(0) increases expression ISO RGD:10439 6480464 Mercury results in increased expression of CYP1B1 protein CTD PMID:22579925 , PMID:23231920 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein] CTD PMID:25110054 metformin decreases expression EXP 6480464 Metformin results in decreased expression of CYP1B1 mRNA, Metformin results in decreased expression of CYP1B1 protein CTD PMID:25110054 methoxsalen decreases activity ISO RGD:10439 6480464 Methoxsalen results in decreased activity of CYP1B1 protein CTD PMID:18420780 methoxychlor increases expression ISO RGD:10439 6480464 Methoxychlor results in increased expression of CYP1B1 mRNA CTD PMID:21514315 methoxychlor decreases activity ISO RGD:10439 6480464 Methoxychlor results in decreased activity of CYP1B1 protein CTD PMID:18420780 methoxychlor decreases expression ISO RGD:2460 6480464 Methoxychlor results in decreased expression of CYP1B1 mRNA CTD PMID:23303685 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CYP1B1 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions EXP 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP1B1 mRNA CTD PMID:27188386 midazolam decreases activity ISO RGD:10439 6480464 Midazolam results in decreased activity of CYP1B1 protein CTD PMID:18420780 mifepristone multiple interactions ISO RGD:2460 6480464 Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]], Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]] CTD PMID:17690134 , PMID:9804617 mono(2-ethylhexyl) phthalate increases expression ISO RGD:2460 6480464 mono-2-ethylhexylphthalate results in increased expression of CYP1B1 mRNA CTD PMID:12706301 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:10439 6480464 [monoethyl phthalate co-treated with mono-2-ethylhexylphthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP1B1 mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO RGD:10439 6480464 [monoethyl phthalate co-treated with mono-2-ethylhexylphthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP1B1 mRNA CTD PMID:31884101 monocrotaline multiple interactions ISO RGD:10439 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP1B1 mRNA CTD PMID:21224054 monoethyl phthalate multiple interactions ISO RGD:10439 6480464 [monoethyl phthalate co-treated with mono-2-ethylhexylphthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP1B1 mRNA CTD PMID:31884101 myricetin decreases activity EXP 6480464 myricetin results in decreased activity of CYP1B1 protein CTD PMID:16271822 , PMID:21482471 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:2460 6480464 N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 protein], N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide inhibits the reaction [TNF protein promotes the reaction [Benzoapyrene results in increased expression of CYP1B1 protein]] CTD PMID:25233930 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 mRNA], N-2-4-bromocinnamylaminoethyl-5-isoquinolinesulfonamide inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 protein] CTD PMID:20093341 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine promotes the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA] CTD PMID:21703343 N-acetyl-L-cysteine multiple interactions ISO RGD:2460 6480464 Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA] CTD PMID:22129741 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases stability EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased stability of CYP1B1 protein CTD PMID:15486049 N-desmethylclozapine increases chemical synthesis EXP 6480464 CYP1B1 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 N-Desmethyltamoxifen decreases activity EXP 6480464 N-desmethyltamoxifen results in decreased activity of CYP1B1 protein CTD PMID:12419016 N-hydroxy-PhIP multiple interactions EXP 6480464 [CYP1B1 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo4 more ... CTD PMID:17279779 N-nitrosodiethylamine multiple interactions ISO RGD:2460 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1B1 mRNA more ... CTD PMID:18164116 more ... N-nitrosodiethylamine increases expression ISO RGD:2460 6480464 Diethylnitrosamine results in increased expression of CYP1B1 mRNA CTD PMID:27565560 NADP zwitterion multiple interactions EXP 6480464 [CYP1B1 protein co-treated with NADP] results in increased metabolism of 2 more ... CTD PMID:15720144 more ... NADP(+) multiple interactions EXP 6480464 [CYP1B1 protein co-treated with NADP] results in increased metabolism of 2 more ... CTD PMID:15720144 more ... naphthalene multiple interactions EXP 6480464 naphthalene binds to and results in decreased activity of CYP1B1 protein CTD PMID:19563207 naphthalene increases expression EXP 6480464 naphthalene results in increased expression of CYP1B1 mRNA CTD PMID:27196671 naphthalenes increases expression ISO RGD:2460 6480464 Naphthalenes results in increased expression of CYP1B1 protein CTD PMID:17337753 naringin multiple interactions EXP 6480464 naringin binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 Nicardipine multiple interactions EXP 6480464 Nicardipine promotes the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA] CTD PMID:20067464 nickel atom affects expression EXP 6480464 Nickel affects the expression of CYP1B1 mRNA CTD PMID:14575637 nickel atom multiple interactions ISO RGD:2460 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of CYP1B1 mRNA CTD PMID:31734292 nickel atom increases expression EXP 6480464 Nickel results in increased expression of CYP1B1 mRNA CTD PMID:25583101 nickel atom multiple interactions EXP 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CYP1B1 mRNA] CTD PMID:14575637 nickel dichloride decreases expression ISO RGD:10439 6480464 nickel chloride results in decreased expression of CYP1B1 mRNA CTD PMID:12839937 , PMID:14645679 nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of CYP1B1 mRNA CTD PMID:12760830 nickel sulfate multiple interactions ISO RGD:2460 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of CYP1B1 mRNA CTD PMID:31734292 nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of CYP1B1 mRNA CTD PMID:22714537 nifedipine decreases activity ISO RGD:10439 6480464 Nifedipine results in decreased activity of CYP1B1 protein CTD PMID:18420780 nimesulide increases glutathionylation EXP 6480464 CYP1B1 protein results in increased glutathionylation of nimesulide CTD PMID:26524229 nobiletin increases expression EXP 6480464 nobiletin results in increased expression of CYP1B1 mRNA CTD PMID:22743247 NS-398 multiple interactions EXP 6480464 N-2-cyclohexyloxy-4-nitrophenylmethanesulfonamide inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 mRNA], N-2-cyclohexyloxy-4-nitrophenylmethanesulfonamide inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 protein] CTD PMID:20093341 O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of CYP1B1 mRNA CTD PMID:32234424 o-xylene decreases expression EXP 6480464 2-xylene results in decreased expression of CYP1B1 mRNA CTD PMID:20359517 okadaic acid multiple interactions EXP 6480464 Okadaic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:10696073 oltipraz decreases activity EXP 6480464 oltipraz metabolite results in decreased activity of CYP1B1 protein CTD PMID:10775323 oltipraz affects activity EXP 6480464 oltipraz affects the activity of CYP1B1 protein CTD PMID:10775323 oltipraz increases expression EXP 6480464 oltipraz results in increased expression of CYP1B1 mRNA CTD PMID:15890477 omeprazole multiple interactions EXP 6480464 Omeprazole promotes the reaction [AHR protein binds to CYP1B1 promoter] more ... CTD PMID:21703235 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CYP1B1 mRNA CTD PMID:25826687 omeprazole decreases activity ISO RGD:10439 6480464 Omeprazole results in decreased activity of CYP1B1 protein CTD PMID:18420780 omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP1B1 mRNA CTD PMID:12040753 more ... organoselenium compound multiple interactions EXP 6480464 Organoselenium Compounds binds to and results in decreased activity of CYP1B1 protein CTD PMID:21732699 oxaliplatin multiple interactions ISO RGD:2460 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CYP1B1 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:2460 6480464 oxaliplatin results in increased expression of CYP1B1 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 AHR protein affects the reaction [Ozone results in increased expression of CYP1B1 mRNA], AHR protein affects the reaction [Ozone results in increased expression of CYP1B1 protein] CTD PMID:19536146 ozone increases expression EXP 6480464 Ozone results in increased expression of CYP1B1 mRNA, Ozone results in increased expression of CYP1B1 protein CTD PMID:19536146 p-chloromercuribenzoic acid increases expression EXP 6480464 p-Chloromercuribenzoic Acid results in increased expression of CYP1B1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP1B1 mRNA CTD PMID:27188386 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of CYP1B1 mRNA CTD PMID:26272509 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP1B1 mRNA CTD PMID:27188386 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP1B1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP1B1 mRNA CTD PMID:25458485 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP1B1 mRNA CTD PMID:26690555 paracetamol affects response to substance EXP 6480464 CYP1B1 gene polymorphism affects the susceptibility to Acetaminophen CTD PMID:26104854 paricalcitol multiple interactions EXP 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP1B1 mRNA CTD PMID:17715259 perfluorononanoic acid decreases expression EXP 6480464 perfluorononanoic acid results in decreased expression of CYP1B1 mRNA CTD PMID:32588087 phenanthrene multiple interactions EXP 6480464 [CYP1B1 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol more ... CTD PMID:15566942 more ... phenanthrene increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of phenanthrene CTD PMID:27137136 phenanthrene decreases metabolic processing EXP 6480464 CYP1B1 gene polymorphism results in decreased metabolism of phenanthrene CTD PMID:17035385 phenanthrenes increases expression EXP 6480464 Phenanthrenes analog results in increased expression of CYP1B1 protein CTD PMID:19365803 phenobarbital increases expression ISO RGD:2460 6480464 Phenobarbital results in increased expression of CYP1B1 mRNA CTD PMID:23273579 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of CYP1B1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP1B1 mRNA CTD PMID:27188386 phenytoin multiple interactions ISO RGD:10439 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP1B1 mRNA CTD PMID:21224054 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased expression of CYP1B1 mRNA CTD PMID:20307560 more ... PhIP increases activity EXP 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased activity of CYP1B1 protein CTD PMID:20307560 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in decreased expression of CYP1B1 mRNA CTD PMID:20702593 PhIP multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo4 more ... CTD PMID:17279779 more ... PhIP increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine CTD PMID:17279779 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] more ... CTD PMID:11728381 , PMID:9706865 phorbol 13-acetate 12-myristate decreases expression ISO RGD:10439 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CYP1B1 mRNA CTD PMID:10037446 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10439 6480464 chelerythrine promotes the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]] more ... CTD PMID:10037446 phosphorus atom multiple interactions EXP 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP1B1 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions EXP 6480464 [Phosphorus co-treated with paricalcitol] results in decreased expression of CYP1B1 mRNA CTD PMID:17715259 piperonyl butoxide increases expression ISO RGD:10439 6480464 Piperonyl Butoxide results in increased expression of CYP1B1 mRNA CTD PMID:10402558 pirinixic acid decreases expression ISO RGD:10439 6480464 pirinixic acid results in decreased expression of CYP1B1 mRNA CTD PMID:16985257 potassium chromate multiple interactions EXP 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of CYP1B1 mRNA CTD PMID:22079256 potassium chromate decreases expression EXP 6480464 potassium chromateVI results in decreased expression of CYP1B1 mRNA CTD PMID:22079256 , PMID:22714537 potassium dichromate decreases expression ISO RGD:10439 6480464 Potassium Dichromate results in decreased expression of CYP1B1 mRNA CTD PMID:23608068 pravastatin increases expression ISO RGD:10439 6480464 Pravastatin results in increased expression of CYP1B1 mRNA CTD PMID:27225895 pravastatin affects expression ISO RGD:2460 6480464 Pravastatin affects the expression of CYP1B1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:10439 6480464 Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1B1 mRNA] CTD PMID:28428138 primaquine increases expression EXP 6480464 Primaquine results in increased expression of CYP1B1 mRNA CTD PMID:12623754 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP1B1 mRNA, prochloraz results in increased expression of CYP1B1 protein CTD PMID:20035023 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of CYP1B1 mRNA CTD PMID:18037150 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYP1B1 mRNA, Progesterone promotes the reaction [laquinimod metabolite results in increased expression of CYP1B1 mRNA] CTD PMID:20660070 , PMID:32668270 progesterone increases expression ISO RGD:2460 6480464 Progesterone results in increased expression of CYP1B1 mRNA CTD PMID:20726854 progesterone decreases expression ISO RGD:2460 6480464 Progesterone results in decreased expression of CYP1B1 protein CTD PMID:8674863 progesterone multiple interactions ISO RGD:2460 6480464 [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benzaanthracene results in increased expression of CYP1B1 protein] more ... CTD PMID:32668270 , PMID:8674863 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP1B1 mRNA CTD PMID:30293151 propranolol multiple interactions EXP 6480464 Propranolol inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:22167199 prostaglandin E2 multiple interactions EXP 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Dinoprostone results in increased expression of CYP1B1 mRNA] more ... CTD PMID:20093341 prostaglandin E2 increases expression EXP 6480464 Dinoprostone results in increased expression of CYP1B1 mRNA, Dinoprostone results in increased expression of CYP1B1 protein CTD PMID:20093341 protein kinase inhibitor multiple interactions EXP 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CYP1B1 mRNA] CTD PMID:28003376 purpurin decreases activity EXP 6480464 purpurin results in decreased activity of CYP1B1 protein CTD PMID:12379470 purpurin increases expression EXP 6480464 purpurin results in increased expression of CYP1B1 mRNA CTD PMID:11502733 pyrene increases hydroxylation EXP 6480464 CYP1B1 protein results in increased hydroxylation of pyrene CTD PMID:15016593 pyrene increases expression EXP 6480464 pyrene results in increased expression of CYP1B1 protein CTD PMID:19365803 pyrene multiple interactions EXP 6480464 [phenanthrene co-treated with pyrene co-treated with Benzoapyrene co-treated with benzokfluoranthene co-treated with dibenzoa more ... CTD PMID:15566942 more ... quercetin decreases activity EXP 6480464 Quercetin results in decreased activity of CYP1B1 protein CTD PMID:16271822 , PMID:21482471 quercetin multiple interactions ISO RGD:10439 6480464 [Quercetin co-treated with Oxygen] results in increased expression of CYP1B1 mRNA CTD PMID:29432836 quercetin decreases activity ISO RGD:10439 6480464 Quercetin results in decreased activity of CYP1B1 protein CTD PMID:18420780 quercetin increases expression ISO RGD:10439 6480464 Quercetin results in increased expression of CYP1B1 mRNA CTD PMID:22334599 quercetin increases expression EXP 6480464 Quercetin results in increased expression of CYP1B1 mRNA CTD PMID:19794518 more ... quercetin multiple interactions EXP 6480464 Quercetin binds to and results in decreased activity of CYP1B1 protein CTD PMID:21053930 quercetin affects expression ISO RGD:2460 6480464 Quercetin affects the expression of CYP1B1 mRNA CTD PMID:18178720 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CYP1B1 mRNA CTD PMID:17637178 quercetin 3-O-beta-D-glucofuranoside decreases activity EXP 6480464 isoquercitrin results in decreased activity of CYP1B1 protein CTD PMID:16271822 quercetin 3-O-beta-D-glucopyranoside decreases activity EXP 6480464 isoquercitrin results in decreased activity of CYP1B1 protein CTD PMID:16271822 quercitrin decreases activity EXP 6480464 quercitrin results in decreased activity of CYP1B1 protein CTD PMID:16271822 quinidine decreases activity ISO RGD:10439 6480464 Quinidine results in decreased activity of CYP1B1 protein CTD PMID:18420780 resveratrol multiple interactions ISO RGD:10439 6480464 [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9 more ... CTD PMID:18694800 more ... resveratrol decreases activity ISO RGD:10439 6480464 resveratrol results in decreased activity of CYP1B1 protein CTD PMID:18420780 , PMID:19329757 resveratrol decreases activity EXP 6480464 resveratrol results in decreased activity of CYP1B1 protein CTD PMID:11714871 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CYP1B1 more ... CTD PMID:11279601 more ... resveratrol affects metabolic processing EXP 6480464 CYP1B1 protein affects the metabolism of resveratrol CTD PMID:15276085 resveratrol multiple interactions EXP 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of CYP1B1 mRNA more ... CTD PMID:11279601 more ... resveratrol affects expression EXP 6480464 resveratrol affects the expression of CYP1B1 protein CTD PMID:15893423 rifampicin multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1B1 mRNA CTD PMID:29162470 rifampicin multiple interactions ISO RGD:10439 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP1B1 mRNA CTD PMID:21224054 Rutecarpine multiple interactions EXP 6480464 rutecarpine analog binds to and results in decreased activity of CYP1B1 protein CTD PMID:12852960 rutin decreases activity EXP 6480464 Rutin results in decreased activity of CYP1B1 protein CTD PMID:16271822 salicylamide multiple interactions EXP 6480464 salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:14729655 sanguinarine increases expression EXP 6480464 sanguinarine results in increased expression of CYP1B1 mRNA CTD PMID:15993743 sanguinarine increases activity EXP 6480464 sanguinarine results in increased activity of CYP1B1 protein CTD PMID:15993743 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 scutellarein decreases activity EXP 6480464 scutellarein results in decreased activity of CYP1B1 protein CTD PMID:21482471 scutellarein multiple interactions EXP 6480464 [CYP1B1 protein affects the metabolism of scutellarein] which results in increased chemical synthesis of 6-hydroxyluteolin CTD PMID:19666078 scutellarein affects metabolic processing EXP 6480464 CYP1B1 protein affects the metabolism of scutellarein CTD PMID:19666078 senecionine increases expression EXP 6480464 senecionine results in increased expression of CYP1B1 mRNA CTD PMID:26100227 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of CYP1B1 mRNA CTD PMID:23806026 , PMID:25895662 sinensetin increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of sinensetin CTD PMID:19666078 skatole increases expression EXP 6480464 Skatole results in increased expression of CYP1B1 mRNA CTD PMID:28571685 sodium acetate trihydrate multiple interactions ISO RGD:10439 6480464 Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA], Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 sodium acetate trihydrate multiple interactions EXP 6480464 Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA], Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYP1B1 mRNA CTD PMID:32525701 sodium arsenate decreases expression ISO RGD:10439 6480464 sodium arsenate results in decreased expression of CYP1B1 mRNA CTD PMID:11353140 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP1B1 mRNA CTD PMID:12727804 , PMID:22714537 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CYP1B1 mRNA CTD PMID:29301061 sodium arsenite affects methylation EXP 6480464 sodium arsenite affects the methylation of CYP1B1 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:10439 6480464 sodium arsenite results in increased expression of CYP1B1 mRNA CTD PMID:25065748 sodium arsenite decreases expression ISO RGD:10439 6480464 sodium arsenite results in decreased expression of CYP1B1 mRNA CTD PMID:11353140 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of CYP1B1 mRNA CTD PMID:12760830 sodium dichromate multiple interactions ISO RGD:10439 6480464 Benzoapyrene promotes the reaction [sodium bichromate results in increased expression of CYP1B1 mRNA] CTD PMID:22613061 sodium dichromate increases expression ISO RGD:10439 6480464 sodium bichromate results in increased expression of CYP1B1 mRNA CTD PMID:22613061 sodium propionate multiple interactions EXP 6480464 sodium propionate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA], sodium propionate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 steviol increases expression EXP 6480464 steviol results in increased expression of CYP1B1 mRNA CTD PMID:28887089 stevioside increases expression EXP 6480464 stevioside results in increased expression of CYP1B1 mRNA CTD PMID:28887089 stilbenoid multiple interactions EXP 6480464 Stilbenes analog inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:18449500 Sudan I increases oxidation EXP 6480464 CYP1B1 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 sulforaphane increases expression ISO RGD:2460 6480464 sulforafan results in increased expression of CYP1B1 protein CTD PMID:18823965 sulforaphane increases expression EXP 6480464 sulforafan results in increased expression of CYP1B1 mRNA CTD PMID:26833863 sulindac increases expression EXP 6480464 Sulindac results in increased expression of CYP1B1 mRNA CTD PMID:17985343 sulindac increases expression ISO RGD:2460 6480464 Sulindac results in increased expression of CYP1B1 mRNA CTD PMID:16531450 sulindac increases activity ISO RGD:2460 6480464 Sulindac results in increased activity of CYP1B1 protein CTD PMID:16531450 sulindac sulfide increases expression EXP 6480464 sulindac sulfide results in increased expression of CYP1B1 mRNA CTD PMID:12734198 , PMID:17985343 sunitinib increases expression ISO RGD:2460 6480464 sunitinib results in increased expression of CYP1B1 mRNA CTD PMID:26797788 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of CYP1B1 mRNA CTD PMID:31533062 suramin multiple interactions EXP 6480464 Suramin inhibits the reaction [Benzoapyrene results in increased expression of CYP1B1 mRNA] CTD PMID:22167199 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of CYP1B1 protein CTD PMID:19812351 tamoxifen decreases activity ISO RGD:10439 6480464 Tamoxifen results in decreased activity of CYP1B1 protein CTD PMID:18420780 tamoxifen decreases activity EXP 6480464 Tamoxifen results in decreased activity of CYP1B1 protein CTD PMID:12419016 tangeretin increases expression EXP 6480464 tangeretin results in increased expression of CYP1B1 protein CTD PMID:29626627 tangeretin increases metabolic processing EXP 6480464 CYP1B1 protein results in increased metabolism of tangeretin CTD PMID:29626627 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of CYP1B1 mRNA CTD PMID:12414654 testosterone decreases activity ISO RGD:10439 6480464 Testosterone results in decreased activity of CYP1B1 protein CTD PMID:18420780 tetrachloromethane increases expression ISO RGD:10439 6480464 Carbon Tetrachloride results in increased expression of CYP1B1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:10439 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CYP1B1 mRNA CTD PMID:30517762 tetrahydrocurcumin multiple interactions ISO RGD:10439 6480464 tetrahydrocurcumin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1B1 mRNA], tetrahydrocurcumin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1B1 protein] CTD PMID:26102010 tetraphene multiple interactions EXP 6480464 [benzaanthracene co-treated with TNF protein] results in increased expression of CYP1B1 mRNA more ... CTD PMID:12224597 , PMID:23396138 tetraphene increases expression ISO RGD:10439 6480464 benzaanthracene results in increased expression of CYP1B1 mRNA, benzaanthracene results in increased expression of CYP1B1 protein CTD PMID:10497882 more ... tetraphene increases expression EXP 6480464 benzaanthracene results in increased expression of CYP1B1 mRNA, benzaanthracene results in increased expression of CYP1B1 protein CTD PMID:12224597 more ... tetraphene increases expression ISO RGD:2460 6480464 benzaanthracene results in increased expression of CYP1B1 mRNA, benzaanthracene results in increased expression of CYP1B1 protein CTD PMID:18205319 more ... tetraphene multiple interactions ISO RGD:2460 6480464 [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] inhibits the reaction [benzaanthracene results in increased expression of CYP1B1 protein] more ... CTD PMID:8674863 tetraphene increases stability ISO RGD:10439 6480464 benzaanthracene results in increased stability of CYP1B1 protein CTD PMID:8022408 tetraphene multiple interactions ISO RGD:10439 6480464 [andrographolide co-treated with benzaanthracene] results in increased expression of CYP1B1 mRNA more ... CTD PMID:10037446 more ... thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of CYP1B1 mRNA CTD PMID:29453283 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Particulate Matter] results in decreased expression of CYP1B1 mRNA CTD PMID:19835593 titanium dioxide increases expression ISO RGD:10439 6480464 titanium dioxide results in increased expression of CYP1B1 mRNA CTD PMID:29264374 titanium dioxide decreases expression ISO RGD:10439 6480464 titanium dioxide results in decreased expression of CYP1B1 mRNA CTD PMID:23557971 toluene decreases expression EXP 6480464 Toluene results in decreased expression of CYP1B1 mRNA CTD PMID:20359517 topotecan multiple interactions ISO RGD:2460 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CYP1B1 mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:2460 6480464 Topotecan results in increased expression of CYP1B1 mRNA CTD PMID:25729387 tranilast affects expression EXP 6480464 tranilast affects the expression of CYP1B1 mRNA CTD PMID:25826687 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP1B1 mRNA CTD PMID:26705709 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP1B1 mRNA CTD PMID:20359517 trichloroethene increases methylation ISO RGD:2460 6480464 Trichloroethylene results in increased methylation of CYP1B1 gene CTD PMID:27618143 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:12927368 more ... trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of CYP1B1 mRNA CTD PMID:12927368 more ... triclocarban multiple interactions EXP 6480464 ESR1 protein affects the reaction [triclocarban results in increased expression of CYP1B1 mRNA] more ... CTD PMID:22761658 , PMID:23524099 triclocarban increases expression ISO RGD:2460 6480464 triclocarban results in increased expression of CYP1B1 mRNA CTD PMID:31576746 triclocarban increases expression ISO RGD:10439 6480464 triclocarban results in increased expression of CYP1B1 mRNA CTD PMID:22761658 triclocarban increases expression EXP 6480464 triclocarban results in increased expression of CYP1B1 mRNA CTD PMID:22761658 triclosan increases expression ISO RGD:2460 6480464 Triclosan results in increased expression of CYP1B1 mRNA CTD PMID:30447264 triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP1B1 mRNA CTD PMID:30510588 trimethylarsine oxide multiple interactions ISO RGD:10439 6480464 trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein] more ... CTD PMID:26042454 , PMID:26144063 trimethylarsine oxide increases expression ISO RGD:10439 6480464 trimethylarsine oxide results in increased expression of CYP1B1 mRNA CTD PMID:26042454 , PMID:26144063 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP1B1 mRNA CTD PMID:19140230 troglitazone increases expression ISO RGD:10439 6480464 troglitazone results in increased expression of CYP1B1 mRNA CTD PMID:28973697 Tungsten carbide multiple interactions EXP 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of CYP1B1 mRNA CTD PMID:18078969 undecane increases expression ISO RGD:2460 6480464 undecane results in increased expression of CYP1B1 protein CTD PMID:17337753 urethane increases expression EXP 6480464 Urethane results in increased expression of CYP1B1 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:10439 6480464 Valproic Acid results in decreased expression of CYP1B1 mRNA CTD PMID:17292431 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP1B1 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYP1B1 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:10439 6480464 Valproic Acid results in increased expression of CYP1B1 mRNA CTD PMID:17292431 , PMID:24896083 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP1B1 mRNA CTD PMID:23179753 , PMID:25192806 vanadium atom multiple interactions ISO RGD:10439 6480464 Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein] more ... CTD PMID:23423713 vanadium(0) multiple interactions ISO RGD:10439 6480464 Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein] more ... CTD PMID:23423713 vancomycin decreases expression ISO RGD:10439 6480464 Vancomycin results in decreased expression of CYP1B1 mRNA CTD PMID:18930951 verapamil decreases activity ISO RGD:10439 6480464 Verapamil results in decreased activity of CYP1B1 protein CTD PMID:18420780 vinclozolin increases expression ISO RGD:2460 6480464 vinclozolin results in increased expression of CYP1B1 mRNA, vinclozolin results in increased expression of CYP1B1 protein CTD PMID:22570695 , PMID:25929820 vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:15713371 , PMID:27188386 vorinostat increases expression EXP 6480464 vorinostat results in increased expression of CYP1B1 mRNA CTD PMID:26272509 vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of CYP1B1 mRNA CTD PMID:18769122 wortmannin multiple interactions ISO RGD:2460 6480464 wortmannin inhibits the reaction [INS1 protein results in decreased expression of CYP1B1 mRNA] CTD PMID:26466350 wortmannin multiple interactions EXP 6480464 [Filipin co-treated with Chlorpromazine co-treated with Wortmannin] inhibits the reaction [Particulate Matter results in increased expression of CYP1B1 mRNA] CTD PMID:29724254 Yessotoxin increases expression EXP 6480464 yessotoxin analog results in increased expression of CYP1B1 mRNA CTD PMID:30679557 zaragozic acid A decreases expression ISO RGD:2460 6480464 squalestatin 1 results in decreased expression of CYP1B1 mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:10439 6480464 squalestatin 1 affects the expression of CYP1B1 mRNA CTD PMID:27225895 zearalenone increases activity EXP 6480464 Zearalenone results in increased activity of CYP1B1 protein CTD PMID:15157572 zearalenone multiple interactions EXP 6480464 Zearalenone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein] CTD PMID:15157572 zidovudine multiple interactions EXP 6480464 [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CYP1B1 mRNA CTD PMID:20370541 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of CYP1B1 mRNA CTD PMID:24714768 , PMID:25596134